<html>
<head>
<META HTTP-EQUIV='Content-Type' CONTENT='text/html; charset=big5'>
<?xml version="1.0" encoding="UTF-8"?> 
<html xmlns="http://www.w3.org/1999/xhtml"
xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2017-03-09/ifrs-full"
xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
xmlns:xbrli="http://www.xbrl.org/2003/instance"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:ix="http://www.xbrl.org/2013/inlineXBRL"
xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26"
xmlns:tifrs-SCF="http://www.xbrl.org/tifrs/scf/2020-06-30"
xmlns:tifrs-ar="http://www.xbrl.org/tifrs/ar/2020-06-30"
xmlns:tifrs-bsci-ci="http://www.xbrl.org/tifrs/bsci/ci/2020-06-30"
xmlns:tifrs-es="http://www.xbrl.org/tifrs/es/2020-06-30"
xmlns:tifrs-notes="http://www.xbrl.org/tifrs/notes/2020-06-30">
<head> 
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 
	<title> 6620 2023Q4 Financial report</title> 
	<script src="https://code.jquery.com/jquery-3.2.1.min.js" type="text/javascript"></script> 
	<script type="text/javascript"> 
		/*<![CDATA[*/ 
		function showChineseReport() { 
			$(".zh").show();
			$(".en").hide();
		}
		function showEnglishReport() {
			$(".en").show();
			$(".zh").hide();
		}
		$(document).ready(function() { 
			if (location.search.indexOf("?") != -1 && 
			location.search.split("?")[1].split("=")[1] == "en") 
				showEnglishReport(); 
			else 
				showChineseReport(); 
		});	
		/*]]>*/ 
	</script> 
	<style type="text/css"> 
		body,html {height: 100%;} 
		body {font-size: 15px;font-family: Arial;color: #000;background: #4E5869;margin: 0;padding: 0;background-color: #FFF;} 
		td,th {border: 1px solid #dddddd;padding: 5px;color: #333;background-color: #FFF;} 
		th#t1 {color: #165c98 !important;} 
		ul,ol,dl {padding: 0;margin: 0;} 
		h3 {color: #165c98;font-size: 18px;} 
		pre {font-size: 15px;font-family: Arial;} 
		.container {width: 100%;background: #FFF;margin: 0 auto;background-color: #999;} 
		.header {text-align: center;background: #165c98;margin-right: auto;color: #fff;} 
		.header > div:first-of-type {position: absolute;right: 15px;top: 15px;} 
		.header > div:nth-of-type(2) {font-size: 25px;text-align: center;line-height: 35px;} 
		.header a {text-decoration: none;margin:0 10px;color: #ffffff;} 
		.nav {float: left;width: 200px;height: calc(100% - 85px);overflow: auto;background: #fff;padding-bottom: 15px;} 
		.nav > div {padding: 10px;color: #165c98;font-size: 20px;font-weight: bold;} 
		.nav > ul {list-style: none;border-top: 1px solid #666;margin-bottom: 15px;} 
		.nav > ul li{border-bottom: 1px solid #666;} 
		.nav > ul a{padding: 5px 2px 5px 10px;display: block;text-decoration: none;background: #fff;color: #333;} 
		.nav > ul a:hover{background: #165c98;color: #fff;} 
		.content {width: calc(100% - 200px);height: calc(100% - 70px); float: left;background: #efefef;overflow: auto;} 
		.content > div[id*="link"] {height: 15px;} 
		.content table {border-collapse: collapse;margin: 0 20px;} 
		.content ul, 
		.content ol {padding: 15px 10px 10px 15px;} 
		.content table tr th {background: #7fcef5;color: #165c98;} 
		.content table tr:first-child th {background: #165c98;color: #fff;font-size: 15px;text-align: left;} 
		.content table tr:nth-of-type(odd) > td {background-color: #d3edfa;} 
		.title {font-size: 18px;font-weight: bold;margin-left: 20px;} 
		.rptidx {color: #000;margin-left: 20px;} 
		.amt {text-align: right} 
		.note {font-family: 細明體} 
		@media print{ 
			.header a{display: none;} 
			.nav{display: none;} 
			.content{width: 100%;height:auto;float: inherit;overflow: inherit;background: #fff!important;} 
			.content table{width: 100%!important;margin: 0;} 
			body{color: #000;} 
			td,th{color: #000;border: 1px solid #000;} 
		} 
	</style> 
</head> 
<body> 
	<div style="display:none"> 
		<ix:header> 
			<ix:hidden> 
				<ix:nonNumeric name="tifrs-notes:CompanyID" contextRef="From20230101To20231231">6620</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyChineseName" contextRef="From20230101To20231231">漢達生技醫藥股份有限公司</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:CompanyEnglishName" contextRef="From20230101To20231231">Handa Pharmaceuticals, Inc.</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Year" contextRef="From20230101To20231231">2023</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Quarter" contextRef="From20230101To20231231">4</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportType" contextRef="From20230101To20231231">Financial report (general)</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:ReportCategory" contextRef="From20230101To20231231">Consolidated report</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:Market" contextRef="From20230101To20231231">Emerging stock market</ix:nonNumeric> 
				<ix:nonNumeric name="tifrs-notes:IndustrySector" contextRef="From20230101To20231231">Commercial and industrial</ix:nonNumeric> 
			</ix:hidden> 
			<ix:references>
				<link:schemaRef xlink:href="tifrs-ci-cr-2020-06-30.xsd" xlink:type="simple"/>
			</ix:references>
			<ix:resources> 
				<xbrli:context id="AsOf20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20240329"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2024-03-29</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OrdinaryShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:OrdinaryShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_PreferenceShareMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:PreferenceShareMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_CapitalReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:CapitalReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_RevaluationSurplusMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RevaluationSurplusMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_StatutoryReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:StatutoryReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInFairValueOfFinancialLiabilityAttributableToChangeInCreditRiskOfLiabilityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_ReserveOfCashFlowHedgesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfCashFlowHedgesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_Total3"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="tifrs-notes:MovementOnAllowanceForDoubtfulAccountsAbstractMemberDimensionMember">tifrs-notes:Total3</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20221231_TreasurySharesMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_NoncontrollingInterestsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_RetainedEarningsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_GainsLossesOnHedgingInstrumentsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnHedgingInstrumentsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_EquityAttributableToOwnersOfParentMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_ReserveOfExchangeDifferencesOnTranslationMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_AdvanceReceiptsForShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:AdvanceReceiptsForShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityAttributableToFomerOwnerOfBusinessCombinationUnderCommonControl</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_CertificateOfEntitlementToNewSharesFromConvertibleBondMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:CertificateOfEntitlementToNewSharesFromConvertibleBondMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:UnappropriatedRetainedEarningsAccumulatedDeficitMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfRemeasurementsOfDefinedBenefitPlansMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_IssuedCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_SecurityTokenOffer"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SecurityTokenOffer</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20230101_GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:GainsLossesOnEffectivePortionOfHedgesOfNetInvestmentsInForeignOperationsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20231231To20231231_TotalEquityMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-12-31</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:TotalEquityMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20220101_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfOverlayApproachMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfOverlayApproachMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20220101To20220101_ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-01-01</xbrli:startDate> 
						<xbrli:endDate>2022-01-01</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20231231_SpecialReserveMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:SpecialReserveMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_Others-OtherEquityInterestMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Others-OtherEquityInterestMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20230101_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2023-01-01</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="AsOf20221231_Other-ShareCapitalMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:instant>2022-12-31</xbrli:instant> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:Other-ShareCapitalMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20221231To20221231_StockDividendToBeDistributedMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2022-12-31</xbrli:startDate> 
						<xbrli:endDate>2022-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:StockDividendToBeDistributedMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:context id="From20230101To20231231_EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember"> 
					<xbrli:entity> 
						<xbrli:identifier scheme="http://www.twse.com.tw">6620</xbrli:identifier> 
					</xbrli:entity> 
					<xbrli:period> 
						<xbrli:startDate>2023-01-01</xbrli:startDate> 
						<xbrli:endDate>2023-12-31</xbrli:endDate> 
					</xbrli:period> 
					<xbrli:scenario> 
						<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">tifrs-es:EquityRelatedToNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForDistributionToOwnersMember</xbrldi:explicitMember> 
					</xbrli:scenario> 
				</xbrli:context> 
				<xbrli:unit id="TWD"> 
					<xbrli:measure>iso4217:TWD</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="Shares"> 
					<xbrli:measure>xbrli:shares</xbrli:measure> 
				</xbrli:unit> 
				<xbrli:unit id="EarningsPerShare"> 
					<xbrli:divide> 
						<xbrli:unitNumerator> 
							<xbrli:measure>iso4217:TWD</xbrli:measure> 
						</xbrli:unitNumerator> 
						<xbrli:unitDenominator> 
							<xbrli:measure>xbrli:shares</xbrli:measure> 
						</xbrli:unitDenominator> 
					</xbrli:divide> 
				</xbrli:unit> 
				<xbrli:unit id="Pure"> 
					<xbrli:measure>xbrli:pure</xbrli:measure> 
				</xbrli:unit> 
			</ix:resources> 
		</ix:header> 
	</div> 
	<div class="container"> 
		<div class="header"> 
			<div> 
				<a href="javascript:showChineseReport();">中文</a>|<a href="javascript:showEnglishReport();">English</a> 
			</div> 
			<div> 
				<span class="zh">6620 漢達生技醫藥股份有限公司<br />2023年第4季合併財務報告</span> 
				<span class="en">6620 Handa Pharmaceuticals, Inc.<br />2023Q4 Consolidated Financial Report</span> 
			</div> 
		</div> 
		<div class="nav"> 
			<div>
				<span class="zh">財務報表索引</span>
				<span class="en">Report Index</span>
			</div> 
			<ul> 
				<li>
					<a href="#BalanceSheet">
						<span class="zh">資產負債表</span>
						<span class="en">Balance Sheet</span>
					</a>
				</li>
				<li>
					<a href="#StatementOfComprehensiveIncome">
						<span class="zh">綜合損益表</span>
						<span class="en">Statement of Comprehensive Income</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfCashFlows">
						<span class="zh">現金流量表</span>
						<span class="en">Statements of Cash Flows</span>
					</a>
				</li> 
				<li>
					<a href="#StatementsOfChangeInEquity">
						<span class="zh">權益變動表</span> 
						<span class="en">Statements of Change in Equity</span>
					</a>
				</li>
				<span class="zh">
	    			<li><a href="#ReportOfIndependentAuditors">會計師查核（核閱）報告</a></li>
	    		</span>
	    		<span class="en">
	    			<li><a href="#ReportOfIndependentAuditorsEN">Independent Auditors' (Review) Report</a></li>
	    		</span>
				<span class="zh">
	    			<li><a style="background-color:#ceceef;">財務報表附註</a></li>
	    			<li><a href="#HistoryAndOrganization">公司沿革及業務範圍</a></li>
	    			<li><a href="#DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">通過財報之日期及程序</a></li>
	    			<li><a href="#ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">新發布及修訂準則及解釋之適用</a></li>
	    			<li><a href="#SummaryOfSignificantAccountingPolicies">重大會計政策之彙總說明</a></li>
	    			<li><a href="#SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">會計重大判斷、假設及估計不確性之主要來源</a></li>
	    			<li><a style="background-color:#ceceef;">其它財報附註</a></li>
	    			<li><a href="#TradeAndOtherReceivables">應收款項</a></li>
	    			<li><a href="#TransactionsBetweenRelatedParties">關係人交易</a></li>
	    			<li><a href="#LoansToOthers">資金貸與他人</a></li>
	    			<li><a href="#EndorsementGuaranteeProvidedToOthers">為他人背書保證</a></li>
	    			<li><a href="#SignificantIntercompanyTransactionsBetweenConsolidatedEntities">母子公司間業務關係及重要交易往來情形</a></li>
	    			<li><a href="#NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">被投資公司名稱、所在地區…等相關資訊</a></li>
	    			<li><a href="#InvestmentInMainlandChina">大陸地區投資</a></li>
	    			<li><a href="#NonoperatingIncomeAndExpenses">營業外收入及支出</a></li>
				</span>
			</ul> 
		</div> 
		<div class="content"> 
			<!-- 資產負債表 -->
			<div id="BalanceSheet"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">資產負債表</span><span class="en">Balance Sheet</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年12月31日</span><span class="en">2023/12/31</span></th> 
						<th><span class="zh">2022年12月31日</span><span class="en">2022/12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">資產</span><span class="en">Assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　流動資產</span><span class="en">　Current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1100</td> 
						<td><span class="zh">　　現金及約當現金</span><span class="en">　　Cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">667,046</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">365,912</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1136</td> 
						<td><span class="zh">　　按攤銷後成本衡量之金融資產－流動</span><span class="en">　　Current financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,652,440</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,591</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1170</td> 
						<td><span class="zh">　　應收帳款淨額</span><span class="en">　　Accounts receivable, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">376,369</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AccountsReceivableNet" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,482</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1200</td> 
						<td><span class="zh">　　其他應收款</span><span class="en">　　Other receivables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,607</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,406</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1220</td> 
						<td><span class="zh">　　本期所得稅資產</span><span class="en">　　Current tax assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">778</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">240</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1470</td> 
						<td><span class="zh">　　其他流動資產</span><span class="en">　　Other current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,634</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">58,226</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">11XX</td> 
						<td><span class="zh">　　流動資產合計</span><span class="en">　　Total current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,714,874</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">592,857</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　非流動資產</span><span class="en">　Non-current assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1550</td> 
						<td><span class="zh">　　採用權益法之投資</span><span class="en">　　Investments accounted for using equity method</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,864</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1600</td> 
						<td><span class="zh">　　不動產、廠房及設備</span><span class="en">　　Property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,662</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,389</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1755</td> 
						<td><span class="zh">　　使用權資產</span><span class="en">　　Right-of-use assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,369</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">28,646</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1780</td> 
						<td><span class="zh">　　無形資產</span><span class="en">　　Intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">35,534</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,016</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1805</td> 
						<td><span class="zh">　　　商譽</span><span class="en">　　　Goodwill</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,949</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">34,949</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1821</td> 
						<td><span class="zh">　　　其他無形資產淨額</span><span class="en">　　　Other intangible assets, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherIntangibleAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">585</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherIntangibleAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,067</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1840</td> 
						<td><span class="zh">　　遞延所得稅資產</span><span class="en">　　Deferred tax assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">202,851</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">117,227</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1900</td> 
						<td><span class="zh">　　其他非流動資產</span><span class="en">　　Other non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,036</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,429</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1920</td> 
						<td><span class="zh">　　　存出保證金</span><span class="en">　　　Guarantee deposits paid</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,036</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GuaranteeDepositsPaid" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,429</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">15XX</td> 
						<td><span class="zh">　　非流動資產合計</span><span class="en">　　Total non-current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">322,316</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">197,707</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">1XXX</td> 
						<td><span class="zh">　資產總計</span><span class="en">　Total assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,037,190</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">790,564</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">負債及權益</span><span class="en">Liabilities and equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　負債</span><span class="en">　Liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　流動負債</span><span class="en">　　Current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2170</td> 
						<td><span class="zh">　　　應付帳款</span><span class="en">　　　Accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,968</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,220</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2200</td> 
						<td><span class="zh">　　　其他應付款</span><span class="en">　　　Other payables</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">55,687</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentPayables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">21,069</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2230</td> 
						<td><span class="zh">　　　本期所得稅負債</span><span class="en">　　　Current tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">124,757</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,337</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2280</td> 
						<td><span class="zh">　　　租賃負債－流動</span><span class="en">　　　Current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,569</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:CurrentLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,139</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2300</td> 
						<td><span class="zh">　　　其他流動負債</span><span class="en">　　　Other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,505</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,589</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2399</td> 
						<td><span class="zh">　　　　其他流動負債－其他</span><span class="en">　　　　Other current liabilities, others</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,505</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherCurrentLiabilitiesOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,589</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">21XX</td> 
						<td><span class="zh">　　　流動負債合計</span><span class="en">　　　Total current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">209,486</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">45,354</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　非流動負債</span><span class="en">　　Non-current liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2570</td> 
						<td><span class="zh">　　　遞延所得稅負債</span><span class="en">　　　Deferred tax liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">23,808</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,633</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2580</td> 
						<td><span class="zh">　　　租賃負債－非流動</span><span class="en">　　　Non-current lease liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">7,671</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentFinanceLeaseLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">19,455</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2600</td> 
						<td><span class="zh">　　　其他非流動負債</span><span class="en">　　　Other non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,916</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">25XX</td> 
						<td><span class="zh">　　　非流動負債合計</span><span class="en">　　　Total non-current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">71,395</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">24,088</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">2XXX</td> 
						<td><span class="zh">　　負債總計</span><span class="en">　　Total liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">280,881</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">69,442</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　權益</span><span class="en">　Equity</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　歸屬於母公司業主之權益</span><span class="en">　　Equity attributable to owners of parent</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　股本</span><span class="en">　　　Share capital</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3110</td> 
						<td><span class="zh">　　　　普通股股本</span><span class="en">　　　　Ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,410,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301,550</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3140</td> 
						<td><span class="zh">　　　　預收股本</span><span class="en">　　　　Advance receipts for share capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AdvanceReceiptsForShareCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:AdvanceReceiptsForShareCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3100</td> 
						<td><span class="zh">　　　　股本合計</span><span class="en">　　　　Total Share Capital</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,410,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301,630</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　資本公積</span><span class="en">　　　Capital surplus</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3200</td> 
						<td><span class="zh">　　　　資本公積合計</span><span class="en">　　　　Total capital surplus</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,253,347</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CapitalReserve" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">579,017</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　保留盈餘</span><span class="en">　　　Retained earnings</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3350</td> 
						<td><span class="zh">　　　　未分配盈餘（或待彌補虧損）</span><span class="en">　　　　Unappropriated retained earnings (accumulated deficit)</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">215,202</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:UnappropriatedRetainedEarningsAaccumulatedDeficit" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,088,684</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3300</td> 
						<td><span class="zh">　　　　保留盈餘合計</span><span class="en">　　　　Total retained earnings</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">215,202</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,088,684</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　其他權益</span><span class="en">　　　Other equity interest</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3410</td> 
						<td><span class="zh">　　　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　　　Exchange differences on translation of foreign financial statements</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">83,786</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">70,841</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3490</td> 
						<td><span class="zh">　　　　其他權益－其他</span><span class="en">　　　　Other equity, others</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:OtherEquityOthers" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherEquityOthers" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3491</td> 
						<td><span class="zh">　　　　　其他權益－員工未賺得酬勞</span><span class="en">　　　　　Other equity, unearned compensation</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:OtherEquityUnearnedCompensation" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OtherEquityUnearnedCompensation" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3400</td> 
						<td><span class="zh">　　　　其他權益合計</span><span class="en">　　　　Total other equity interest</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">123,180</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherEquityInterest" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">70,841</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">31XX</td> 
						<td><span class="zh">　　　歸屬於母公司業主之權益合計</span><span class="en">　　　Total equity attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,756,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">721,122</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3XXX</td> 
						<td><span class="zh">　　權益總額</span><span class="en">　　Total equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,756,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">721,122</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3X2X</td> 
						<td><span class="zh">　負債及權益總計</span><span class="en">　Total liabilities and equity</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,037,190</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">790,564</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3998</td> 
						<td><span class="zh">　預收股款（權益項下）之約當發行股數</span><span class="en">　Equivalent issue shares of advance receipts for ordinary share</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">3,000</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">3999</td> 
						<td><span class="zh">　母公司暨子公司所持有之母公司庫藏股股數（單位：股）</span><span class="en">　Number of shares in entity held by entity and by its subsidiaries</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries" contextRef="AsOf20221231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 綜合損益表 -->
			<div id="StatementOfComprehensiveIncome"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元　每股盈餘單位：新台幣元</span><span class="en">Unit: NT$ thousands　EPS Unit: NT$</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">綜合損益表</span><span class="en">Statement of Comprehensive Income</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年1月1日至12月31日</span><span class="en">2023/1/1To12/31</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業收入</span><span class="en">Operating revenue</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　銷貨收入淨額</span><span class="en">　Net sales revenue</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">4100</td> 
						<td><span class="zh">　　銷貨收入淨額</span><span class="en">　　Net sales revenue</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,106,320</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">197,676</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">4000</td> 
						<td><span class="zh">　營業收入合計</span><span class="en">　Total operating revenue</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,106,320</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Revenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">197,676</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業成本</span><span class="en">Operating costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　銷貨成本</span><span class="en">　Cost of sales</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5110</td> 
						<td><span class="zh">　　銷貨成本合計</span><span class="en">　　Total cost of sales</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,711</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5000</td> 
						<td><span class="zh">　營業成本合計</span><span class="en">　Total operating costs</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:OperatingCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,711</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5900</td> 
						<td><span class="zh">營業毛利（毛損）</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,105,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:GrossProfitLossFromOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">178,965</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">5950</td> 
						<td><span class="zh">營業毛利（毛損）淨額</span><span class="en">Gross profit (loss) from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,105,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">178,965</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業費用</span><span class="en">Operating expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6100</td> 
						<td><span class="zh">　推銷費用</span><span class="en">　Selling expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">26,991</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:SellingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">20,900</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6200</td> 
						<td><span class="zh">　管理費用</span><span class="en">　Administrative expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">77,881</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdministrativeExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">66,409</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6300</td> 
						<td><span class="zh">　研究發展費用</span><span class="en">　Research and development expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">306,720</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">179,776</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6000</td> 
						<td><span class="zh">　營業費用合計</span><span class="en">　Total operating expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">411,592</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OperatingExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">267,085</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">6900</td> 
						<td><span class="zh">營業利益（損失）</span><span class="en">Net operating income (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">693,427</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">88,120</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業外收入及支出</span><span class="en">Non-operating income and expenses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　利息收入</span><span class="en">　Interest income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7100</td> 
						<td><span class="zh">　　利息收入合計</span><span class="en">　　Total interest income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,160</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">502</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他收入</span><span class="en">　Other income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7010</td> 
						<td><span class="zh">　　其他收入合計</span><span class="en">　　Total other income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,406</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">764</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　其他利益及損失</span><span class="en">　Other gains and losses</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7020</td> 
						<td><span class="zh">　　其他利益及損失淨額</span><span class="en">　　Other gains and losses, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,348</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,985</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　財務成本</span><span class="en">　Finance costs</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7050</td> 
						<td><span class="zh">　　財務成本淨額</span><span class="en">　　Finance costs, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">222</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">281</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　採用權益法認列之關聯企業及合資損益之份額</span><span class="en">　Share of profit (loss) of associates and joint ventures accounted for using equity method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7060</td> 
						<td><span class="zh">　　採用權益法認列之關聯企業及合資損益之份額淨額</span><span class="en">　　Share of profit (loss) of associates and joint ventures accounted for using equity method, net</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,368</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7000</td> 
						<td><span class="zh">　營業外收入及支出合計</span><span class="en">　Total non-operating income and expenses</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">99,060</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-bsci-ci:NonoperatingIncomeAndExpenses" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,970</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7900</td> 
						<td><span class="zh">繼續營業單位稅前淨利（淨損）</span><span class="en">Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">792,487</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,150</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">所得稅費用（利益）</span><span class="en">Tax expense (income)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">7950</td> 
						<td><span class="zh">　所得稅費用（利益）合計</span><span class="en">　Total tax expense (income)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">65,601</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,139</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8000</td> 
						<td><span class="zh">繼續營業單位本期淨利（淨損）</span><span class="en">Profit (loss) from continuing operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8200</td> 
						<td><span class="zh">本期淨利（淨損）</span><span class="en">Profit (loss)</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">其他綜合損益(淨額)</span><span class="en">Other comprehensive income</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　不重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8341</td> 
						<td><span class="zh">　　不重分類至損益之其他項目</span><span class="en">　　Other components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:OtherComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,073</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-bsci-ci:OtherComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">76,299</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8310</td> 
						<td><span class="zh">　　不重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will not be reclassified to profit or loss</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">17,073</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">76,299</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　後續可能重分類至損益之項目</span><span class="en">　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8361</td> 
						<td><span class="zh">　　國外營運機構財務報表換算之兌換差額</span><span class="en">　　Exchange differences on translation</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,103</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">53,387</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8370</td> 
						<td><span class="zh">　　採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目</span><span class="en">　　Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8360</td> 
						<td><span class="zh">　　後續可能重分類至損益之項目總額</span><span class="en">　　Components of other comprehensive income that will be reclassified to profit or loss</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,128</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">53,387</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8300</td> 
						<td><span class="zh">　其他綜合損益（淨額）</span><span class="en">　Total other comprehensive income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8500</td> 
						<td><span class="zh">本期綜合損益總額</span><span class="en">Total comprehensive income</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">713,941</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">62,923</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">淨利（損）歸屬於：</span><span class="en">Profit (loss), attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8610</td> 
						<td><span class="zh">　母公司業主（淨利／損）</span><span class="en">　Profit (loss), attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">綜合損益總額歸屬於：</span><span class="en">Comprehensive income attributable to:</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">8710</td> 
						<td><span class="zh">　母公司業主（綜合損益）</span><span class="en">　Comprehensive income, attributable to owners of parent</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">713,941</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">62,923</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">基本每股盈餘</span><span class="en">Basic earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9710</td> 
						<td><span class="zh">　繼續營業單位淨利（淨損）</span><span class="en">　Basic earnings (loss) per share from continuing operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">5.41</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">0.32</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9750</td> 
						<td><span class="zh">　基本每股盈餘合計</span><span class="en">　Total basic earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">5.41</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">0.32</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">稀釋每股盈餘</span><span class="en">Diluted earnings per share</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9810</td> 
						<td><span class="zh">　繼續營業單位淨利（淨損）</span><span class="en">　Diluted earnings (loss) per share from continuing operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">5.40</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">0.32</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">9850</td> 
						<td><span class="zh">　稀釋每股盈餘合計</span><span class="en">　Total diluted earnings per share</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="0" decimals="2" unitRef="EarningsPerShare">5.40</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="0" sign="-" decimals="2" unitRef="EarningsPerShare">0.32</ix:nonFraction>)</pre></td>
					</tr> 
				</table> 
				<br /> 
			<!-- 現金流量表 -->
			<div id="StatementsOfCashFlows"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:90%"> 
					<tr><th colspan="4"><span class="zh">現金流量表</span><span class="en">Statements of Cash Flows</span></th></tr> 
					<tr> 
						<th><span class="zh">代號</span><span class="en">Code</span></th> 
						<th><span class="zh">會計項目</span><span class="en">Accounting Title</span></th> 
						<th><span class="zh">2023年1月1日至12月31日</span><span class="en">2023/1/1To12/31</span></th> 
						<th><span class="zh">2022年1月1日至12月31日</span><span class="en">2022/1/1To12/31</span></th> 
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">營業活動之現金流量－間接法</span><span class="en">Cash flows from (used in) operating activities, indirect method</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A00010</td> 
						<td><span class="zh">　繼續營業單位稅前淨利（淨損）</span><span class="en">　Profit (loss) from continuing operations before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">792,487</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,150</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A10000</td> 
						<td><span class="zh">　本期稅前淨利（淨損）</span><span class="en">　Profit (loss) before tax</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">792,487</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ProfitLossBeforeTax" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">43,150</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　調整項目</span><span class="en">　Adjustments</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　收益費損項目</span><span class="en">　　Adjustments to reconcile profit (loss)</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20100</td> 
						<td><span class="zh">　　　折舊費用</span><span class="en">　　　Depreciation expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,145</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">14,821</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20200</td> 
						<td><span class="zh">　　　攤銷費用</span><span class="en">　　　Amortization expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">298</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">360</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20900</td> 
						<td><span class="zh">　　　利息費用</span><span class="en">　　　Interest expense</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">222</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForInterestExpense" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">281</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21200</td> 
						<td><span class="zh">　　　利息收入</span><span class="en">　　　Interest income</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">18,160</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForInterestIncome" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">502</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A21900</td> 
						<td><span class="zh">　　　股份基礎給付酬勞成本</span><span class="en">　　　Share-based payments</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,465</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">112</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22300</td> 
						<td><span class="zh">　　　採用權益法認列之關聯企業及合資損失（利益）之份額</span><span class="en">　　　Share of loss (profit) of associates and joint ventures accounted for using equity method</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ShareOfLossProfitOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,368</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ShareOfLossProfitOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A22500</td> 
						<td><span class="zh">　　　處分及報廢不動產、廠房及設備損失（利益）</span><span class="en">　　　Loss (gain) on disposal of property, plan and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A23200</td> 
						<td><span class="zh">　　　處分採用權益法之投資損失（利益）</span><span class="en">　　　Loss (gain) on disposal of investments accounted for using equity method</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,612</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20010</td> 
						<td><span class="zh">　　　收益費損項目合計</span><span class="en">　　　Total adjustments to reconcile profit (loss)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">4,005</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:AdjustmentsToReconcileProfitLoss" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,074</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　與營業活動相關之資產／負債變動數</span><span class="en">　　Changes in operating assets and liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之資產之淨變動</span><span class="en">　　　Changes in operating assets</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31150</td> 
						<td><span class="zh">　　　　應收帳款（增加）減少</span><span class="en">　　　　Decrease (increase) in accounts receivable</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">226,179</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInAccountsReceivable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">140,577</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31180</td> 
						<td><span class="zh">　　　　其他應收款（增加）減少</span><span class="en">　　　　Decrease (increase) in other receivable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,451</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInOtherReceivables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,001</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31200</td> 
						<td><span class="zh">　　　　存貨（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in inventories</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">10,105</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31230</td> 
						<td><span class="zh">　　　　預付款項（增加）減少</span><span class="en">　　　　Decrease (increase) in prepayments</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">3,458</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:DecreaseIncreaseInPrepayments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,032</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31240</td> 
						<td><span class="zh">　　　　其他流動資產（增加）減少</span><span class="en">　　　　Adjustments for decrease (increase) in other current assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,385</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">46,647</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A31000</td> 
						<td><span class="zh">　　　　與營業活動相關之資產之淨變動合計</span><span class="en">　　　　Total changes in operating assets</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">171,801</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssets" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">190,152</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">　　　與營業活動相關之負債之淨變動</span><span class="en">　　　Changes in operating liabilities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32150</td> 
						<td><span class="zh">　　　　應付帳款增加（減少）</span><span class="en">　　　　Increase (decrease) in accounts payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,342</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInAccountsPayable" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,096</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32180</td> 
						<td><span class="zh">　　　　其他應付款增加（減少）</span><span class="en">　　　　Increase (decrease) in other payable</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">36,216</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseDecreaseInOtherPayables" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,479</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32230</td> 
						<td><span class="zh">　　　　其他流動負債增加（減少）</span><span class="en">　　　　Adjustments for increase (decrease) in other current liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,918</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">272</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A32000</td> 
						<td><span class="zh">　　　　與營業活動相關之負債之淨變動合計</span><span class="en">　　　　Total changes in operating liabilities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">47,476</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ChangesInOperatingLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,847</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A30000</td> 
						<td><span class="zh">　　　與營業活動相關之資產及負債之淨變動合計</span><span class="en">　　　Total changes in operating assets and liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">124,325</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:ChangesInOperatingAssetsAndLiabilities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">181,305</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A20000</td> 
						<td><span class="zh">　　調整項目合計</span><span class="en">　　Total adjustments</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">128,330</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:Adjustments" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">166,231</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33000</td> 
						<td><span class="zh">　營運產生之現金流入（流出）</span><span class="en">　Cash inflow (outflow) generated from operations</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">664,157</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">209,381</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33100</td> 
						<td><span class="zh">　收取之利息</span><span class="en">　Interest received</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,205</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">513</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33300</td> 
						<td><span class="zh">　支付之利息</span><span class="en">　Interest paid</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">222</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">281</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">A33500</td> 
						<td><span class="zh">　退還（支付）之所得稅</span><span class="en">　Income taxes refund (paid)</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,780</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2,422</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">AAAA</td> 
						<td><span class="zh">營業活動之淨現金流入（流出）</span><span class="en">Net cash flows from (used in) operating activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">668,360</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">211,571</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">投資活動之現金流量</span><span class="en">Cash flows from (used in) investing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00040</td> 
						<td><span class="zh">　取得按攤銷後成本衡量之金融資產</span><span class="en">　Acquisition of financial assets at amortised cost</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,754,556</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:AcquisitionOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,754</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B00050</td> 
						<td><span class="zh">　處分按攤銷後成本衡量之金融資產</span><span class="en">　Proceeds from disposal of financial assets at amortised cost</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">101,974</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ProceedsFromDisposalOfFinancialAssetsAtAmortisedCost" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">38,460</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02300</td> 
						<td><span class="zh">　處分子公司</span><span class="en">　Proceeds from disposal of subsidiaries</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">10,974</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02700</td> 
						<td><span class="zh">　取得不動產、廠房及設備</span><span class="en">　Acquisition of property, plant and equipment</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">944</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">639</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B02800</td> 
						<td><span class="zh">　處分不動產、廠房及設備</span><span class="en">　Proceeds from disposal of property, plant and equipment</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B03700</td> 
						<td><span class="zh">　存出保證金增加</span><span class="en">　Increase in refundable deposits</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:IncreaseInRefundableDeposits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">447</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">B04500</td> 
						<td><span class="zh">　取得無形資產</span><span class="en">　Acquisition of intangible assets</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">119</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">BBBB</td> 
						<td><span class="zh">　投資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) investing activities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,664,500</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:NetCashFlowsFromUsedInInvestingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">29,503</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center"></td> 
						<td><span class="zh">籌資活動之現金流量</span><span class="en">Cash flows from (used in) financing activities</span></td>
						<td class="amt"></td>
						<td class="amt"></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04020</td> 
						<td><span class="zh">　租賃本金償還</span><span class="en">　Payments of lease liabilities</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,165</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">7,185</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04600</td> 
						<td><span class="zh">　現金增資</span><span class="en">　Proceeds from issuing shares</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,300,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">320,000</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C04800</td> 
						<td><span class="zh">　員工執行認股權</span><span class="en">　Exercise of employee share options</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,773</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:ExerciseOfEmployeeShareOptions" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">830</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">C09900</td> 
						<td><span class="zh">　其他籌資活動</span><span class="en">　Other financing activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">CCCC</td> 
						<td><span class="zh">　籌資活動之淨現金流入（流出）</span><span class="en">　Net cash flows from (used in) financing activities</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,305,616</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashFlowsFromUsedInFinancingActivities" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">313,645</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">DDDD</td> 
						<td><span class="zh">匯率變動對現金及約當現金之影響</span><span class="en">Effect of exchange rate changes on cash and cash equivalents</span></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">8,342</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">28,974</ix:nonFraction>)</pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">EEEE</td> 
						<td><span class="zh">本期現金及約當現金增加（減少）數</span><span class="en">Net increase (decrease) in cash and cash equivalents</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">301,134</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">102,603</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00100</td> 
						<td><span class="zh">期初現金及約當現金餘額</span><span class="en">Cash and cash equivalents at beginning of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">365,912</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtBeginningOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">263,309</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00200</td> 
						<td><span class="zh">期末現金及約當現金餘額</span><span class="en">Cash and cash equivalents at end of period</span></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">667,046</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-SCF:CashAndCashEquivalentsAtEndOfPeriod" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">365,912</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<td style="text-align:center">E00210</td> 
						<td><span class="zh">　資產負債表帳列之現金及約當現金</span><span class="en">　Cash and cash equivalents reported in the statement of financial position</span></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">667,046</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">365,912</ix:nonFraction> </pre></td>
					</tr> 

				</table> 
				<br /> 
			<!-- 當期權益變動表 -->
			<div id="StatementsOfChangeInEquity"></div> 
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">當期權益變動表</span><span class="en">Statements of Change in Equity</span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3140</th>
						<th>3100</th>
						<th>3200</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3490</th>
						<th>3400</th>
						<th>31XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">預收股本</span> 
							<span class="en">　　　　　Advance receipts for share capital</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">其他</span> 
							<span class="en">　　　　　Others</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301,550</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301,630</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">579,017</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,088,684</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,088,684</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">70,841</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_Others-OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">70,841</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">721,122</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20230101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">721,122</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C11</td> 
						<td> 
							<span class="zh">資本公積彌補虧損</span> 
							<span class="en">　　Capital surplus used to offset accumulated deficits</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">577,000</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">577,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">577,000</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:CapitalSurplusUsedToOffsetAccumulatedDeficits" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>C17</td> 
						<td> 
							<span class="zh">其他資本公積變動數</span> 
							<span class="en">　　Other changes in capital surplus</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:OtherChangesInCapitalSurplus" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td> 
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">726,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">713,941</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">713,941</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>E1</td> 
						<td> 
							<span class="zh">現金增資</span> 
							<span class="en">　Issue of shares</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100,000</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">100,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,200,000</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,300,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,300,000</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,000</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">42,859</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_Others-OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,465</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,465</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>T1</td> 
						<td> 
							<span class="zh">其他</span> 
							<span class="en">　Others</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,390</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">80</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,310</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">8,463</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,773</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,773</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">109,390</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">80</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">109,310</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">674,330</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,303,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,303,886</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">12,945</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_Others-OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">52,339</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,035,187</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20230101To20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,035,187</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td> 
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,410,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,410,940</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,253,347</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">215,202</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">215,202</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">83,786</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_Others-OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">39,394</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">123,180</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,756,309</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20231231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,756,309</ix:nonFraction> </pre></td>
					</tr>
				</table> 
				<br /> 
			<!-- 去年同期權益變動表 -->
			<div class="rptidx"><span class="zh">單位：新臺幣仟元</span><span class="en">Unit: NT$ thousands</span></div> 
				<table style="width:150%"> 
					<tr> 
						<th colspan="32"> 
							<span class="zh">去年同期權益變動表</span><span class="en"> Last year's Statements of Change in Equity </span> 
						</th> 
					</tr> 
					<tr> 
						<th colspan='2' rowspan='2'></th> 
						<th>3110</th>
						<th>3140</th>
						<th>3100</th>
						<th>3200</th>
						<th>3350</th>
						<th>3300</th>
						<th>3410</th>
						<th>3400</th>
						<th>31XX</th>
						<th>3XXX</th>
					</tr> 
					<tr> 
						<th> 
							<span class="zh">普通股股本</span> 
							<span class="en">　　　　　Ordinary share</span> 
						</th>
						<th> 
							<span class="zh">預收股本</span> 
							<span class="en">　　　　　Advance receipts for share capital</span> 
						</th>
						<th> 
							<span class="zh">股本合計</span> 
							<span class="en">　　　　Total share capital</span> 
						</th>
						<th> 
							<span class="zh">資本公積</span> 
							<span class="en">　　　　Capital surplus</span> 
						</th>
						<th> 
							<span class="zh">未分配盈餘（或待彌補虧損）</span> 
							<span class="en">　　　　　Unappropriated retained earnings (accumulated deficit)</span> 
						</th>
						<th> 
							<span class="zh">保留盈餘合計</span> 
							<span class="en">　　　　Total retained earnings</span> 
						</th>
						<th> 
							<span class="zh">國外營運機構財務報表換算之兌換差額</span> 
							<span class="en">　　　　　Exchange differences on translation of foreign financial statements</span> 
						</th>
						<th> 
							<span class="zh">其他權益項目合計</span> 
							<span class="en">　　　　Total other equity interest</span> 
						</th>
						<th> 
							<span class="zh">歸屬於母公司業主之權益總計</span> 
							<span class="en">　　　Total equity attributable to owners of parent</span> 
						</th>
						<th> 
							<span class="zh">權益總額</span> 
							<span class="en">　　Total equity</span> 
						</th>
					</tr> 
					<tr> 
						<td>A1</td> 
						<td> 
							<span class="zh">期初餘額</span> 
							<span class="en">　Equity at beginning of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,221,300</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,221,300</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">338,405</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,048,673</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,048,673</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,929</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">47,929</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">463,103</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20220101_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">463,103</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>D1</td> 
						<td> 
							<span class="zh">本期淨利（淨損）</span> 
							<span class="en">　Profit (loss)</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D3</td> 
						<td> 
							<span class="zh">本期其他綜合損益</span> 
							<span class="en">　Other comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>D5</td> 
						<td> 
							<span class="zh">本期綜合損益總額</span> 
							<span class="en">　Total comprehensive income</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">62,923</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">62,923</ix:nonFraction>)</pre></td>
					</tr>
					<tr> 
						<td>E1</td> 
						<td> 
							<span class="zh">現金增資</span> 
							<span class="en">　Issue of shares</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,000</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">240,000</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">320,000</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:IssueOfShares" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">320,000</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>N1</td> 
						<td> 
							<span class="zh">股份基礎給付</span> 
							<span class="en">　Share-based payments</span> 
						</td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">112</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">112</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">112</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>T1</td> 
						<td> 
							<span class="zh">其他</span> 
							<span class="en">　Others</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">250</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20220101To20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">330</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">500</ix:nonFraction> </pre></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">830</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-es:Others-IncreaseDecreaseInEquity" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">830</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Y1</td> 
						<td> 
							<span class="zh">權益增加(減少)總額</span> 
							<span class="en">　Total increase (decrease) in equity</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,250</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80,330</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">240,612</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">40,011</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">22,912</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">258,019</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:ChangesInEquity" contextRef="From20220101To20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">258,019</ix:nonFraction> </pre></td>
					</tr>
					<tr> 
						<td>Z1</td> 
						<td> 
							<span class="zh">期末餘額</span> 
							<span class="en">　Equity at end of period</span> 
						</td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OrdinaryShareMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301,550</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_AdvanceReceiptsForShareCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">80</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_IssuedCapitalMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,301,630</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_CapitalReserveMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">579,017</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_UnappropriatedRetainedEarningsAccumulatedDeficitMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,088,684</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_RetainedEarningsMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">1,088,684</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_ReserveOfExchangeDifferencesOnTranslationMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">70,841</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_OtherEquityInterestMember" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">70,841</ix:nonFraction>)</pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">721,122</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf20221231_TotalEquityMember" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">721,122</ix:nonFraction> </pre></td>
					</tr>

				</table> 
				<br /> 
			<!-- 會計師查核報告 -->	
			<div id="ReportOfIndependentAuditors"></div> 
			<span class="zh">
			<div class="rptidx">單位：新臺幣仟元</div> 
				<table> 
					<tr>
						<th colspan="3">會計師查核（核閱）報告</th> 
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師事務所名稱</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AccountantName" contextRef="AsOf20240329" xml:lang="zh" escape="true">勤業眾信聯合會計師事務所</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 1</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName1" contextRef="AsOf20240329" xml:lang="zh" escape="true">黃秀椿</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簽證會計師名稱 2</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AssuranceAccountantName2" contextRef="AsOf20240329" xml:lang="zh" escape="true">蔡侑玲</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核日期</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:ReviewAuditDate" contextRef="AsOf20240329" xml:lang="zh" escape="true">2024-03-29</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 查核報告</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:AuditReport" contextRef="AsOf20240329" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 核閱或查核報告類型</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　　 無保留意見/結論</th> 
						<td colspan="2"><pre><ix:nonNumeric name="tifrs-ar:UnqualifiedOpinionAbstract" contextRef="AsOf20240329" xml:lang="zh" escape="true">Y</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 報告類型細分</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述強調事項內容</th> 
						<td colspan="2"></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 簡述其他事項內容</th> 
						<td colspan="2"><pre class="note"><ix:nonNumeric name="tifrs-ar:DescriptionOtherItemBody" contextRef="AsOf20240329" xml:lang="zh" escape="true">漢達生技醫藥股份有限公司業已編製民國112及111年度之個體財務報告，並經本會計師出具無保留意見之查核報告在案，備供參考。</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left;width:600px;">　 會計師查核(核閱)報告內容</th> 
						<td colspan="2"><pre class="note"><ix:nonNumeric name="tifrs-ar:AccountantsReportBody" contextRef="AsOf20240329" xml:lang="zh" escape="true">　　　　　　　　　　　　　會計師查核報告
 

漢達生技醫藥股份有限公司　公鑒：

查核意見
　　漢達生技醫藥股份有限公司及其子公司（漢達集團）民國112年及111年
12月31日之合併資產負債表，暨民國112年及111年1月1日至12月31日
之合併綜合損益表、合併權益變動表、合併現金流量表，以及合併財務報告附
註（包括重大會計政策彙總），業經本會計師查核竣事。
　　依本會計師之意見，上開合併財務報告在所有重大方面係依照證券發行
人財務報告編製準則及經金融監督管理委員會認可並發布生效之國際財務報
導準則、國際會計準則、解釋及解釋公告編製，足以允當表達漢達集團民國112
年及111年12月31日之合併財務狀況，暨民國112年及111年1月1日至
12月31日之合併財務績效及合併現金流量。
查核意見之基礎
　　本會計師係依照會計師受託查核簽證財務報表規則及審計準則執行查核
工作。本會計師於該等準則下之責任將於會計師查核合併財務報告之責任段
進一步說明。本會計師所隸屬事務所受獨立性規範之人員已依會計師職業道
德規範，與漢達集團保持超然獨立，並履行該規範之其他責任。本會計師相信
已取得足夠及適切之查核證據，以作為表示查核意見之基礎。
關鍵查核事項
　　關鍵查核事項係指依本會計師之專業判斷，對漢達集團民國112年度合
併財務報告之查核最為重要之事項。該等事項已於查核合併財務報告整體及
形成查核意見之過程中予以因應，本會計師並不對該等事項單獨表示意見。
　　茲對漢達集團民國112年度合併財務報告之關鍵查核事項敘明如下：
分潤權利金收入認列之正確性
　　漢達集團係專注於開發具市場發展潛力之505(b)(2)新藥及高技術門檻之
利基型學名藥，並授權予合作夥伴於特定地區銷售該藥品，其中以藥品銷售淨
利潤之特定比例計算之分潤權利金，係授權收入之重要組成部分。漢達集團於
民國112年度認列之分潤權利金收入金額為新台幣1,028,432仟元（美金
33,010仟元），佔合併營業收入93%，該等分潤權利金收入認列之正確性將對
合併財務報告產生重大影響，因是列為關鍵查核事項。
　　收入認列相關會計政策暨攸關揭露資訊，請參閱合併財務報告附註四及
十九。
　　本會計師已執行之主要查核程序如下：
 1. 對與收入認列攸關之內部控制取得必要之了解，以評估內部控制之設計
　　與執行情形。
 2. 檢視相關合約及往來對帳文件，以驗證當年度分潤權利金收入之認列是
　　否正確。
 3. 對授權對象發函詢證。
 4. 檢視收款情形，以確認收款金額及對象是否存在重大異常情事。
其他事項
　　漢達生技醫藥股份有限公司業已編製民國112及111年度之個體財務報
告，並經本會計師出具無保留意見之查核報告在案，備供參考。
管理階層與治理單位對合併財務報告之責任
　　管理階層之責任係依照證券發行人財務報告編製準則及經金融監督管理
委員會認可並發布生效之國際財務報導準則、國際會計準則、解釋及解釋公告
編製允當表達之合併財務報告，且維持與合併財務報告編製有關之必要內部
控制，以確保合併財務報告未存有導因於舞弊或錯誤之重大不實表達。
　　於編製合併財務報告時，管理階層之責任亦包括評估漢達集團繼續經營
之能力、相關事項之揭露，以及繼續經營會計基礎之採用，除非管理階層意圖
清算漢達集團或停止營業，或除清算或停業外別無實際可行之其他方案。
　　漢達集團之治理單位（含審計委員會）負有監督財務報導流程之責任。
會計師查核合併財務報告之責任
　　本會計師查核合併財務報告之目的，係對合併財務報告整體是否存有導
因於舞弊或錯誤之重大不實表達取得合理確信，並出具查核報告。合理確信係
高度確信，惟依照審計準則執行之查核工作無法保證必能偵出合併財務報告
存有之重大不實表達。不實表達可能導因於舞弊或錯誤。如不實表達之個別金
額或彙總數可合理預期將影響合併財務報告使用者所作之經濟決策，則被認
為具有重大性。
　　本會計師依照審計準則查核時，運用專業判斷及專業懷疑。本會計師亦執
行下列工作：
 1. 辨認並評估合併財務報告導因於舞弊或錯誤之重大不實表達風險；對所
    評估之風險設計及執行適當之因應對策；並取得足夠及適切之查核證據
    以作為查核意見之基礎。因舞弊可能涉及共謀、偽造、故意遺漏、不實聲
    明或踰越內部控制，故未偵出導因於舞弊之重大不實表達之風險高於導
    因於錯誤者。
 2. 對與查核攸關之內部控制取得必要之瞭解，以設計當時情況下適當之查
    核程序，惟其目的非對漢達集團內部控制之有效性表示意見。
 3. 評估管理階層所採用會計政策之適當性，及其所作會計估計與相關揭露
    之合理性。
 4. 依據所取得之查核證據，對管理階層採用繼續經營會計基礎之適當性，以
    及使漢達集團繼續經營之能力可能產生重大疑慮之事件或情況是否存在
    重大不確定性，作出結論。本會計師若認為該等事件或情況存在重大不確
    定性，則須於查核報告中提醒合併財務報告使用者注意合併財務報告之
　　相關揭露，或於該等揭露係屬不適當時修正查核意見。本會計師之結論係
　　以截至查核報告日所取得之查核證據為基礎。惟未來事件或情況可能導
　　致漢達集團不再具有繼續經營之能力。
 5. 評估合併財務報告（包括相關附註）之整體表達、結構及內容，以及合併
　　財務報告是否允當表達相關交易及事件。
 6. 對於集團內組成個體之財務資訊取得足夠及適切之查核證據，以對合併
　　財務報告表示意見。本會計師負責集團查核案件之指導、監督及執行，並
　　負責形成集團查核意見。
　　本會計師與治理單位溝通之事項，包括所規劃之查核範圍及時間，以及重
大查核發現（包括於查核過程中所辨認之內部控制顯著缺失）。
　　本會計師從與治理單位溝通之事項中，決定對漢達集團民國112年度合
併財務報告查核之關鍵查核事項。本會計師於查核報告中敘明該等事項，除非
法令不允許公開揭露特定事項，或在極罕見情況下，本會計師決定不於查核報
告中溝通特定事項，因可合理預期此溝通所產生之負面影響大於所增進之公
眾利益。







勤業眾信聯合會計師事務所
會 計 師　 黃　　秀　 　椿　　　會 計 師　　蔡　　侑　　玲





證券暨期貨管理委員會核准文號　　　　金融監督管理委員會核准文號
　　台財證六字第0920123784號	　　　金管證審字第1100356048號
　









中　　華　　民　　國　　113　　年　　3　　月　　29　　日
</ix:nonNumeric></pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之子公司營業收入淨額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:TotalYearToDateRevenuesOfSubsidiariesWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止採用其他會計師查核意見(核閱報告)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfProfitLossForTheQuarterOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereAuditedOrReviewedByOtherIndependentAccountants" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司期末資產總額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfAssetsOfSubsidiariesWhoseFinancialStatementsWereOnUnauditedOrUnreviewed" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之子公司綜合損益金額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:YearToDateComprehensiveIncomeOfSubsidiariesWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資期末餘額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:EndingBalanceOfInvestmentsAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan="2">　 截至本季止未經會計師查核(核閱)之採用權益法之投資當期認列關聯企業及合資損益之份額</th> 
						<td class="amt" style="width:100px"><pre><ix:nonFraction name="tifrs-ar:ShareOfYearToDateProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodWhoseFinancialStatementsWereUnauditedOrUnreviewed" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD" xml:lang="zh">0</ix:nonFraction> </pre></td>
					</tr> 
				</table>
			</span>

			<br />
			<span class="zh">
			<div class="title">財務報表附註</div>
			<div id="HistoryAndOrganization">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">公司沿革及業務範圍</th>
					</tr> 
					<tr>
						<td>　 公司沿革及業務範圍</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:HistoryAndOrganization" contextRef="From20230101To20231231" escape="true">
　　漢達生技醫藥股份有限公司（以下簡稱「本公司」）於103年5月
8日核准設立。
　　本公司於104年10月29日經董事會決議以現金720,000仟元（美
金21,654仟元）收購Handa Pharmaceuticals, LLC及其子公司杭州漢
達醫藥科技有限公司之全部股權，Handa Pharmaceuticals, LLC股東
於收到收購對價後認購本公司於105年2月新發行之普通股。此項併
購案經綜合判斷後為反向併購，故以本公司名義所發布之合併財務報
告，係以法律上子公司（即為Handa Pharmaceuticals, LLC及其子公
司）為主體之延續。本公司股票自105年12月起經財團法人中華民國
證券櫃檯買賣中心核准，於該中心之興櫃股票櫃檯買賣。
　　本公司主要從事利用藥物傳輸及控釋技術平台，投入高障礙或特
殊劑型學名藥品及505(b)(2)新藥之開發及銷售。
　　法律上子公司（即為Handa Pharmaceuticals, LLC及其子公司）
之功能性貨幣為美金，為增加財務報告之比較性及一致性，本合併財務
報告係以新台幣表達。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="DateAndProceduresOfAuthorisationForIssueOfFinancialStatements">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">通過財報之日期及程序</th>
					</tr> 
					<tr>
						<td>　 通過財報之日期及程序</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DateAndProceduresOfAuthorisationForIssueOfFinancialStatements" contextRef="From20230101To20231231" escape="true">
　　本合併財務報告於113年3月29日經董事會通過。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">新發布及修訂準則及解釋之適用</th>
					</tr> 
					<tr>
						<td>　 新發布及修訂準則及解釋之適用</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ApplicationOfNewlyIssuedOrAmendedStandardsAndInterpretations" contextRef="From20230101To20231231" escape="true">
(一)首次適用金融監督管理委員會（以下稱「金管會」）認可並發布生效
　　之國際財務報導準則（IFRS）、國際會計準則（IAS）、解釋（IFRIC）
　　及解釋公告（SIC）（以下稱「IFRS會計準則」）
　　　　合併公司評估首次適用金管會認可並發布生效之IFRS會計準則
　　將不致造成合併公司會計政策之重大變動。
(二)113年適用之金管會認可之IFRS會計準則
　　新發布／修正／修訂準則及解釋	　　　  IASB發布之生效日（註1）
　　------------------------------------    　  ---------------------- 
　　IFRS 16之修正「售後租回中之租賃負債」　　   2024年1月1日（註2）
　　IAS 1之修正「負債分類為流動或非流動」　　   2024年1月1日
　　IAS 1之修正「具合約條款之非流動負債」　　   2024年1月1日
　　IAS 7及IFRS 7之修正「供應商融資安排」　　   2024年1月1日（註3）

    註1：除另註明外，上述新發布／修正／修訂準則或解釋係於各該
         日期以後開始之年度報導期間生效。
　　註2：賣方兼承租人應對初次適用IFRS 16日後簽訂之售後租回交
　　　　 易追溯適用IFRS 16之修正。
　　註3：第一次適用本修正時，豁免部分揭露規定。
　　   截至本合併財務報告通過發布日止，合併公司評估上述準則、解
    釋之修正對合併公司財務狀況與財務績效並無重大影響。
(三)IASB已發布但尚未經金管會認可並發布生效之IFRS會計準則
    新發布／修正／修訂準則及解釋	         IASB發布之生效日（註1）
    -----------------------------------------    ----------------------
　　IFRS 10及IAS 28之修正「投資者與其關聯企業　  未　　定
　　或合資間之資產出售或投入」		
　　IFRS 17「保險合約」		　　　　　　　   2023年1月1日
　　IFRS 17之修正		　　　　　　　   2023年1月1日
　　IFRS 17之修正「初次適用IFRS 17及IFRS 9－比   2023年1月1日
　　較資訊」		
　　IAS 21之修正「缺乏可兌換性」	         2025年1月1日（註2）

　　註1：除另註明外，上述新發布／修正／修訂準則或解釋係於各該
         日期以後開始之年度報導期間生效。
　　註2：適用於2025年1月1日以後開始之年度報導期間。首次適用
         該修正時，將影響數認列於首次適用日之保留盈餘。當合併公
         司以非功能性貨幣作為表達貨幣時，將影響數調整首次適用
         日權益項下之國外營運機構兌換差額。
　　   截至本合併財務報告通過發布日止，合併公司仍持續評估上述
    準則、解釋之修正對財務狀況與財務績效之影響，相關影響待評估完
    成時予以揭露。
(四)表達重分類
　　   為提升財務報告使用者之閱讀，合併公司之管理階層認為將營業
    費用中屬反托拉斯法訴訟案件相關之律師費表達為管理費用較為適
    當，故於112年改變合併綜合損益表之表達，111年度比較資訊並予
    以重分類，俾使表達一致。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>
			<br />
			<div id="SummaryOfSignificantAccountingPolicies">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計政策之彙總說明</th>
					</tr> 
					<tr>
						<td>　 遵循聲明</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:StatementOfIFRSAndRelatedRegulationsCompliance" contextRef="From20230101To20231231" escape="true">
(一)遵循聲明
　　    本合併財務報告係依照證券發行人財務報告編製準則及經金管
　　會認可並發布生效之IFRS會計準則編製。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 編製基礎</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:BasisOfPreparation" contextRef="From20230101To20231231" escape="true">
(二)編製基礎
　　　　本合併財務報告係依歷史成本基礎編製。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 合併報表編製原則</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PrinciplesOfConsolidation" contextRef="From20230101To20231231" escape="true">
(四)合併基礎
　　　　本合併財務報告係包含本公司及由本公司所控制個體（子公司）
　　之財務報告。合併綜合損益表已納入被收購或被處分子公司於當期
　　自收購日起或至處分日止之營運損益。子公司之財務報告已予調整，
　　以使其會計政策與合併公司之會計政策一致。於編製合併財務報告
　　時，各個體間之交易、帳戶餘額、收益及費損已全數予以銷除。
　　　　當合併公司喪失對子公司之控制時，處分損益係為下列兩者之
　　差額：(1)所收取對價之公允價值與對前子公司之剩餘投資按喪失控
　　制日之公允價值合計數，以及(2)前子公司之資產（含商譽）與負債
　　及非控制權益按喪失控制日之帳面金額合計數。合併公司對於其他
　　綜合損益中所認列與該子公司有關之所有金額，其會計處理係與合
　　併公司直接處分相關資產或負債所必須遵循之基礎相同。
　　　　對前子公司剩餘投資係按喪失控制日之公允價值作為原始認列
　　投資關聯企業之金額。
　　　　子公司明細、持股比率及營業項目，參閱附註九、附表三及四。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th colspan='30' rowspan='1' style="text-align:left">列入合併財務報表之子公司</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">子公司名稱</th> 
						<th colspan='1' rowspan='2' style="text-align:center">業務性質</th> 
						<th colspan='2' rowspan='1' style="text-align:center">所持股權百分比</th> 
						<th colspan='1' rowspan='2' style="text-align:center">說明</th> 
					</tr>
					<tr> 
						<th colspan='1' rowspan='1' style="text-align:center">本期</th> 
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th> 
					</tr>
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">本 公 司</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">轉投資控股與醫藥產品之市場開發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">醫藥產品之研究與市場開發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Handa Oncology,LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">醫藥產品之研究與市場開發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">Handa Neuroscience,LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">醫藥產品之研究與市場開發</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<ix:tuple name="tifrs-notes:TheConsolidatedEntities">
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:NameOfInvestee" contextRef="From20230101To20231231" escape="true">杭州漢達醫藥科技有限公司（杭州漢達）</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:MainBusinesses" contextRef="From20230101To20231231" escape="true">醫藥製劑之技術開發及服務提供</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td>
						<td style="text-align:center"><pre class="note"><ix:nonNumeric name="tifrs-notes:Description" contextRef="From20230101To20231231" escape="true"> </ix:nonNumeric></pre></td>
						</ix:tuple>
					</tr> 
					<tr> 
						<th style="text-align:left" colspan='1'>備註</th>
						<td colspan='7' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-TheConsolidatedEntities" contextRef="From20230101To20231231" escape="true">本公司於105年2月以現金720,000仟元（美金21,654仟元）取
得Handa Pharmaceuticals, LLC 及其100%持有之子公司杭州漢達之
全部股權。
　　為強化集團內專業分工及美國藥品市場之開發能量，本公司於109
年7月7日經董事會決議設立100%持股之子公司Handa Pharma, Inc.，
再透過該子公司設立100%持股之孫公司Handa Neuroscience, LLC與
Handa Oncology, LLC，本公司並將原持有Handa Pharmaceuticals,
LLC之股權以美金2,100仟元作價全數出售予Handa Pharma, Inc.，
前項股權交易係屬共同控制下之組織重組，相關出售及取得股權之交
易採帳面價值法入帳，視為自始即已發生。
　　本公司董事會於111年4月14日決議由本公司現金增資子公司
Handa Pharma, Inc.美金3,000仟元，前述增資已於111年4月完成。
　　本公司董事會於111年7月13日決議由本公司資金貸與子公司
Handa Pharma, Inc.美金2,000仟元，再由子公司Handa Pharma, Inc.
現金增資予其子公司Handa Oncology, LLC美金1,500仟元，前述增
資已於111年7月完成。
　　本公司董事會於111年10月12日決議由本公司現金增資子公司
Handa Pharma, Inc. 美金2,500仟元，再由子公司Handa Pharma, Inc.
分別現金增資子公司Handa Neuroscience, LLC及Handa Oncology,
LLC美金400仟元及美金2,000仟元，前述增資已於111年10月完成。
　　為因應營運發展所需，本公司董事會於112年4月7日決議由子
公司Handa Pharmaceuticals, LLC現金增資其100%持有之子公司杭
州漢達美金1,300仟元（已於112年4月完成），並決議由Handa
Pharmaceuticals, LLC、杭州漢達與上海延安醫藥洋浦股份有限公司
（以下稱「延安醫藥」）於112年4月共同簽訂增資及合資協議。依據
該等協議之約定，杭州漢達後續分階段辦理之現金增資，將全數由延安
醫藥認繳，延安醫藥與合併公司對杭州漢達之認繳出資額比例分別為
51%及49%，股東會（即杭州漢達之最高權力機構）之決議係按前述認
繳出資額比例行使股東表決權利。經綜合評估，合併公司係自112年6
月5日起喪失對杭州漢達之控制力，請參閱附註十。</ix:nonNumeric></pre></td>
					</tr> 
				</table> 
			<div style="text-align:center">未列入合併財務報表之子公司</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td>　 外幣</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ForeignCurrencies" contextRef="From20230101To20231231" escape="true">
(五)外　　幣
　　　　各個體編製財務報告時，以個體功能性貨幣以外之貨幣（外幣）
　　交易者，依交易日匯率換算為功能性貨幣記錄。
　　　　外幣貨幣性項目於每一資產負債表日以收盤匯率換算。因交割
　　貨幣性項目或換算貨幣性項目產生之兌換差額，於發生當期認列於
　　損益。
　　　　以公允價值衡量之外幣非貨幣性項目係以決定公允價值當日之
　　匯率換算，所產生之兌換差額列為當期損益，惟屬公允價值變動認列
　　於其他綜合損益者，其產生之兌換差額列於其他綜合損益。
　　　　以歷史成本衡量之外幣非貨幣性項目係以交易日之匯率換算，
　　不再重新換算。
　　　　於編製合併財務報告時，國外營運機構（包含營運所在國家或使
　　用之貨幣與本公司不同之子公司）之資產及負債以每一資產負債表
　　日匯率換算為新台幣。收益及費損項目係以當期平均匯率換算，所產
　　生之兌換差額列於其他綜合損益。
　　　　若合併公司處分國外營運機構之所有權益，或處分國外營運機
　　構之子公司部分權益但喪失控制，或處分國外營運機構之後之保留
　　權益係金融資產並按金融工具之會計政策處理，所有與該國外營運
　　機構相關之累計兌換差額將重分類至損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 資產與負債區分流動與非流動之標準</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ClassificationOfCurrentAndNoncurrentAssetsAndLiabilities" contextRef="From20230101To20231231" escape="true">
(三)資產與負債區分流動與非流動之標準
　　　　流動資產包括：
 　　 1.主要為交易目的而持有之資產；
      2.預期於資產負債表日後12個月內實現之資產；及
      3.現金及約當現金（但不包括於資產負債表日後逾12個月用以交
        換或清償負債而受到限制者）。
　　　　流動負債包括：
      1.主要為交易目的而持有之負債；
      2.於資產負債表日後12個月內到期清償之負債，以及
      3.不能無條件將清償期限遞延至資產負債表日後至少12個月之負
        債。
　　    非屬上述流動資產或流動負債者，係分類為非流動資產或非流
    動負債。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 金融工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialInstruments" contextRef="From20230101To20231231" escape="true">
(十一)金融工具
　　　　　金融資產與金融負債於合併公司成為該工具合約條款之一方時
　　　認列於合併資產負債表。
　　　　　原始認列金融資產與金融負債時，若金融資產或金融負債非屬
　　　透過損益按公允價值衡量者，係按公允價值加計直接可歸屬於取得
　　　或發行金融資產或金融負債之交易成本衡量。直接可歸屬於取得或
　　　發行透過損益按公允價值衡量之金融資產或金融負債之交易成本，
　　　則立即認列為損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialAssets" contextRef="From20230101To20231231" escape="true">
1.金融資產
　　　金融資產之慣例交易係採交易日會計認列及除列。
 　(1)衡量種類
　　　　　合併公司所持有之金融資產種類均為按攤銷後成本衡
　　　量之金融資產。
　　　　　合併公司投資金融資產若同時符合下列兩條件，則分
　　　類為按攤銷後成本衡量之金融資產：
　　　A.係於某經營模式下持有，該模式之目的係持有金融資產
　　　　以收取合約現金流量；及
　　　B.合約條款產生特定日期之現金流量，該等現金流量完全
　　　　為支付本金及流通在外本金金額之利息。
　　　　　按攤銷後成本衡量之金融資產（包括現金及約當現金、
　　　原始到期日超過3個月之定期存款、質押定存單、按攤銷
　　　後成本衡量之應收帳款與其他應收款）於原始認列後，係以
　　　有效利息法決定之總帳面金額減除任何減損損失之攤銷後
　　　成本衡量，任何外幣兌換損益則認列於損益。
　　　　　除下列兩種情況外，利息收入係以有效利率乘以金融
　　　資產總帳面金額計算：
　　　A.購入或創始之信用減損金融資產，利息收入係以信用調
　　　　整後有效利率乘以金融資產攤銷後成本計算。
　　　B.非屬購入或創始之信用減損，但後續變成信用減損之金
　　　　融資產，應自信用減損後之次一報導期間起以有效利率
　　　　乘以金融資產攤銷後成本計算利息收入。
　　　　　信用減損金融資產係指發行人或債務人已發生重大財
　　　務困難、違約、債務人很有可能聲請破產或其他財務重整或
　　　由於財務困難而使金融資產之活絡市場消失。
　　　　　約當現金包括自取得日起3個月內、高度流動性、可
　　　隨時轉換成定額現金且價值變動風險甚小之定期存款，係
　　　用於滿足短期現金承諾。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfFinancialAssets" contextRef="From20230101To20231231" escape="true">
(2)金融資產之減損
　　　 合併公司於每一資產負債表日按預期信用損失評估按
　 攤銷後成本衡量之金融資產（含應收帳款）之減損損失。
　　   應收帳款均按存續期間預期信用損失認列備抵損失。
   其他金融資產係先評估自原始認列後信用風險是否顯著增
   加，若未顯著增加，則按12個月預期信用損失認列備抵損
   失，若已顯著增加，則按存續期間預期信用損失認列備抵損
   失。
　　   預期信用損失係以發生違約之風險作為權重之加權平
   均信用損失。12個月預期信用損失係代表金融工具於報導
   日後12個月內可能違約事項所產生之預期信用損失，存續
   期間預期信用損失則代表金融工具於預期存續期間所有可
   能違約事項產生之預期信用損失。
　　   合併公司為內部信用風險管理目的，在不考量所持有
   擔保品之前提下，判定如有內部或外部資訊顯示債務人已
   不可能清償債務時，代表金融資產已發生違約。
　　   所有金融資產之減損損失係藉由備抵帳戶調降其帳面
   金額。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融資產之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialAssets" contextRef="From20230101To20231231" escape="true">
(3)金融資產之除列
　　   合併公司僅於對來自金融資產現金流量之合約權利失
   效，或已移轉金融資產且該資產所有權之幾乎所有風險及
   報酬已移轉予其他企業時，始將金融資產除列。
　　   按攤銷後成本衡量之金融資產整體除列時，其帳面金
   額與所收取對價間之差額係認列於損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　 金融負債及權益工具</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:FinancialLiabilitiesAndEquityInstruments" contextRef="From20230101To20231231" escape="true">
2.權益工具
　　　合併公司發行之權益工具係以取得之價款扣除直接發行成
　本後之金額認列。
3.金融負債
 　(1)後續衡量
　　　　　所有金融負債係以有效利息法按攤銷後成本衡量。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　　　 金融負債之除列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:DerecognitionOfFinancialLiabilities" contextRef="From20230101To20231231" escape="true">
   (2)金融負債之除列
　　　 　 除列金融負債時，其帳面金額與所支付對價（包含任何
　 　 所移轉之非現金資產或承擔之負債）間之差額認列為損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 投資關聯企業</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:InvestmentsInAssociates" contextRef="From20230101To20231231" escape="true">
(六)投資關聯企業
　　　　關聯企業係指合併公司具有重大影響，但非屬子公司或合資之
　　企業。
　　　　合併公司對投資關聯企業係採用權益法。
　　　　權益法下，投資關聯企業原始依成本認列，取得日後帳面金額係
　　隨合併公司所享有之關聯企業損益及其他綜合損益份額與利潤分配
　　而增減。此外，針對關聯企業權益之變動係按持股比例認列。
　　　　取得成本超過合併公司於取得日所享有關聯企業可辨認資產及
　　負債淨公允價值份額之數額列為商譽，該商譽係包含於該投資之帳
　　面金額且不得攤銷；合併公司於取得日所享有關聯企業可辨認資產
　　及負債淨公允價值份額超過取得成本之數額列為當期損益。
　　　　關聯企業發行新股時，合併公司若未按持股比例認購，致使持股
　　比例發生變動，並因而使投資之股權淨值發生增減時，其增減數調整
　　資本公積－採權益法認列關聯企業及合資股權淨值之變動數及採用
　　權益法之投資。惟若未按持股比例認購或取得致使對關聯企業之所
　　有權權益減少者，於其他綜合損益中所認列與該關聯企業有關之金
　　額按減少比例重分類，其會計處理之基礎係與關聯企業若直接處分
　　相關資產或負債所必須遵循之基礎相同；前項調整如應借記資本公
　　積，而採用權益法之投資所產生之資本公積餘額不足時，其差額借記
　　保留盈餘。
　　　　當合併公司對關聯企業之損失份額等於或超過其在該關聯企業
　　權益（包括權益法下投資關聯企業之帳面金額及實質上屬於合併公
　　司對該關聯企業淨投資組成部分之其他長期權益）時，即停止認列進
　　一步之損失。合併公司僅於發生法定義務、推定義務或已代關聯企業
　　支付款項之範圍內，認列額外損失及負債。
　　　　合併公司於評估減損時，係將投資之整體帳面金額（含商譽）視
　　為單一資產比較可回收金額與帳面金額，進行減損測試，所認列之減
　　損損失不分攤至構成投資帳面金額組成部分之任何資產，包括商譽。
　　減損損失之任何迴轉，於該投資之可回收金額後續增加之範圍內予
　　以認列。
　　　　合併公司自其投資不再為關聯企業之日停止採用權益法，其對
　　原關聯企業之保留權益以公允價值衡量，該公允價值及處分價款與
　　停止採用權益法當日之投資帳面金額之差額，列入當期損益。此外，
　　於其他綜合損益中所認列與該關聯企業有關之所有金額，其會計處
　　理之基礎係與關聯企業若直接處分相關資產或負債所必須遵循之基
　　礎相同。若對關聯企業之投資成為合資之投資，或對合資之投資成為
　　對關聯企業之投資，合併公司係持續採用權益法而不對保留權益作
　　再衡量。
　　　　合併公司與關聯企業之逆流、順流及側流交易所產生之損益，僅
　　在與合併公司對關聯企業權益無關之範圍內，認列於合併財務報告。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 不動產（、廠房）及設備</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:PropertyPlantAndEquipment" contextRef="From20230101To20231231" escape="true">
(七)不動產、廠房及設備
　　　　不動產、廠房及設備係以成本認列，後續以成本減除累計折舊及
　　累計減損損失後之金額衡量。
　　　　建造中之不動產、廠房及設備係以成本減除累計減損損失後之
　　金額認列。成本包括專業服務費用及符合資本化條件之借款成本。該
　　等資產於完工並達預期使用狀態時，分類至不動產、廠房及設備之適
　　當類別並開始提列折舊。
　　　　不動產、廠房及設備於耐用年限內按直線基礎，對每一重大部分
　　單獨提列折舊。合併公司至少於每一年度結束日對估計耐用年限、殘
　　值及折舊方法進行檢視，並推延適用會計估計值變動之影響。
　　　　不動產、廠房及設備除列時，淨處分價款與該資產帳面金額間之
　　差額係認列於損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 租賃</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Leasing" contextRef="From20230101To20231231" escape="true">
(十三)租　　賃
　　　　　合併公司於合約成立日評估合約是否係屬（或包含）租賃。
　　　合併公司為承租人
　　　　　除適用認列豁免之低價值標的資產租賃及短期租賃之租賃給付
　　　係按直線基礎於租賃期間內認列為費用，其他租賃皆於租賃開始日
　　　認列使用權資產及租賃負債。
　　　　　使用權資產原始按成本（包含租賃負債之原始衡量金額、租賃開
　　　始日前支付之租賃給付減除收取之租賃誘因、原始直接成本及復原
　　　標的資產之估計成本）衡量，後續按成本減除累計折舊後之金額衡量，
　　　並調整租賃負債之再衡量數。使用權資產係單獨表達於合併資產負
　　　債表。
　　　　　使用權資產採直線基礎自租賃開始日起至耐用年限屆滿時或租
　　　賃期間屆滿時兩者之較早者提列折舊。
　　　　　租賃負債原始按租賃給付（包含實質固定給付）之現值衡量。若
　　　租賃隱含利率容易確定，租賃給付使用該利率折現。若該利率並非容
　　　易確定，則使用承租人增額借款利率。
　　　　　後續，租賃負債採有效利息法按攤銷後成本基礎衡量，且利息費
　　　用係於租賃期間分攤。若租賃期間變動導致未來租賃給付有變動，合
　　　併公司再衡量租賃負債，並相對調整使用權資產，惟若使用權資產之
　　　帳面金額已減至零，則剩餘之再衡量金額認列於損益中。租賃負債係
　　　單獨表達於合併資產負債表。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 無形資產</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IntangibleAssets" contextRef="From20230101To20231231" escape="true">
(八)商　　譽
　　　　企業合併所取得之商譽係依收購日所認列之商譽金額作為成本，
　　後續以成本減除累計減損損失後之金額衡量。
　　　　為減損測試之目的，商譽分攤至合併公司預期因該合併綜效而
　　受益之各現金產生單位或現金產生單位群組（簡稱「現金產生單位」）。
　　　　受攤商譽之現金產生單位每年（及有跡象顯示該單位可能已減
　　損時）藉由包含商譽之該單位帳面金額與其可回收金額之比較，進行
　　該單位之減損測試。若分攤至現金產生單位之商譽係當年度企業合
　　併所取得，則該單位應於當年度結束前進行減損測試。若受攤商譽之
　　現金產生單位之可回收金額低於其帳面金額，減損損失係先減少該
　　現金產生單位受攤商譽之帳面金額，次就該單位內其他各資產帳面
　　金額之比例減少各該資產帳面金額。任何減損損失直接認列為當期
　　損失。商譽減損損失不得於後續期間迴轉。
　　　　處分受攤商譽現金產生單位內之某一營運時，與該被處分營運
　　有關之商譽金額係包含於營運之帳面金額以決定處分損益。
(九)無形資產
 　　 1.單獨取得
　　        單獨取得之有限耐用年限無形資產原始以成本衡量，後續
　　　　係以成本減除累計攤銷及累計減損損失後之金額衡量。無形資
　　　　產於耐用年限內按直線基礎或其他合併公司管理階層認為可反
　　　　映合併公司預期資產未來經濟效益之消耗型態基礎進行攤銷，
　　　　合併公司至少於每一年度結束日對估計耐用年限、殘值及攤銷
　　　　方法進行檢視，並推延適用會計估計值變動之影響。非確定耐用
　　　　年限無形資產係以成本減除累計減損損失列報。
 　　 2.內部產生－研究及發展支出
　　　　　　研究之支出於發生時認列為費用。
　　　　　　合併公司於符合下列所有條件時，開始認列內部計畫發展
　　　　階段之無形資產：
 　　　　(1)完成無形資產之技術可行性已達成，將使該無形資產可供
　　　　　　使用或出售；
 　　　　(2)意圖完成該無形資產，並加以使用或出售；
 　　　　(3)有能力使用或出售該無形資產；
 　　　　(4)無形資產將產生很有可能之未來經濟效益；
 　　　　(5)具充足之技術、財務及其他資源完成此項發展，並使用或出
　　　　　　售該無形資產；及
 　　　　(6)歸屬於該無形資產發展階段之支出，能夠可靠衡量。
　　　　　　內部產生無形資產之成本係自首次均符合上述條件之日起
　　　　所發生之支出總和認列，後續衡量方式與單獨取得之無形資產
　　　　相同。
 　　 3.企業合併所取得
　　　　　　企業合併所取得之無形資產係以收購日之公允價值認列，
　　　　並與商譽分別認列，後續衡量方式與單獨取得之無形資產相同。
      4.除　　列
　　　　　　無形資產除列時，淨處分價款與該資產帳面金額間之差額
　　　　係認列於當期損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 非金融資產減損</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ImpairmentOfNonFinancialAsset" contextRef="From20230101To20231231" escape="true">
(十)不動產、廠房及設備、使用權資產及無形資產（商譽除外）之減損
　　　　合併公司於每一資產負債表日評估是否有任何跡象顯示不動產、
　　廠房及設備、使用權資產及無形資產（商譽除外）可能已減損。若有
　　任一減損跡象存在，則估計該資產之可回收金額。倘無法估計個別資
　　產之可回收金額，合併公司估計該資產所屬現金產生單位之可回收
　　金額。
　　　　針對非確定耐用年限及尚未可供使用之無形資產，至少每年及
　　有減損跡象時進行減損測試。
　　　　可回收金額為公允價值減出售成本與其使用價值之較高者。個
　　別資產或現金產生單位之可回收金額若低於其帳面金額時，將該資
　　產或現金產生單位之帳面金額調減至其可回收金額，減損損失係認
　　列於損益。
　　　　當減損損失於後續迴轉時，該資產或現金產生單位之帳面金額
　　調增至修訂後之可回收金額，惟增加後之帳面金額以不超過該資產
　　或現金產生單位若未於以前年度認列減損損失時所決定之帳面金額
　　（減除攤銷或折舊）。減損損失之迴轉係認列於損益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 收入之認列</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:RevenueRecognition" contextRef="From20230101To20231231" escape="true">
(十二)收入認列
　　　　　合併公司於客戶合約辨認履約義務後，將交易價格分攤至各履
　　　約義務，並於滿足各履約義務時認列收入。
　　　授權收入
　　　　　智慧財產權授權或出售收入係於下述條件滿足時認列為收入：
　　　權利交付予第三方、金額可確定回收及未有關於該權利無法區分之
　　　未來履約義務。
　　　　　合併公司對以銷售基礎計算之權利金係於下列事項較晚發生者
　　　發生時認列授權收入：
 　　　(1)發生後續銷售或使用；與
 　　　(2)已分攤部分或全部以銷售基礎計算之權利金履約義務已滿足。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 員工福利</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:EmployeeBenefits" contextRef="From20230101To20231231" escape="true">
(十四)員工福利
 　　　 1.短期員工福利
　　　　　　　短期員工福利相關負債係以換取員工服務而預期支付之非
　　　　　折現金額衡量。
        2.退職後福利
　　　　　　　確定提撥退休計畫之退休金係於員工提供服務期間將應提
　　　　　撥之退休金數額認列為費用。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 股份基礎給付</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ShareBasedPayment" contextRef="From20230101To20231231" escape="true">
(十五)股份基礎給付協議
　　　給與員工之員工認股權及限制員工權利股票
　　　　　員工認股權及限制員工權利股票係按給與日權益工具之公允價
　　　值及預期既得之最佳估計數量，於既得期間內以直線基礎認列費用，
　　　並同時調整資本公積－員工認股權及其他權益－員工未賺得酬勞。
　　　若其於給與日立即既得，係於給與日全數認列費用。
　　　　　合併公司發行限制員工權利股票時，係於給與日認列其他權益
　　　－員工未賺得酬勞，並同時調整資本公積—限制員工權利股票。若屬
　　　有償發行，且約定員工離職時須退還價款者，應認列相關應付款。若
　　　員工於既得期間內離職無須返還已領取之股利，於宣告發放股利時
　　　認列費用，並同時調整保留盈餘及資本公積—限制員工權利股票。
　　　　　合併公司於每一資產負債表日修正預期既得之員工認股權及限
　　　制員工權利股票估計數量。若有修正原估計數量，其影響數係認列為
　　　損益，使累計費用反映修正之估計值，並相對調整資本公積－員工認
　　　股權及資本公積—限制員工權利股票。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td>　 所得稅</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:IncomeTax" contextRef="From20230101To20231231" escape="true">
(十六)所 得 稅
　　　　　所得稅費用係當期所得稅及遞延所得稅之總和。
 　　　 1.當期所得稅
　　　　　　　合併公司依各所得稅申報轄區所制定之法規決定當期所得
　　　　　（損失），據以計算應付（可回收）之所得稅。
　　　　　　　依中華民國所得稅法規定計算之未分配盈餘加徵所得稅，
　　　　　係於股東會決議年度認列。
　　　　　　　以前年度應付所得稅之調整，列入當期所得稅。
 　　　 2.遞延所得稅
　　　　　　　遞延所得稅係依帳載資產及負債帳面金額與計算課稅所得
          之課稅基礎二者所產生之暫時性差異計算。此外，原始認列商譽
　　　　　產生之應課稅暫時性差異不認列遞延所得稅負債。
　　　　　　　遞延所得稅負債一般係就所有應課稅暫時性差異予以認列，
          而遞延所得稅資產則於很有可能有課稅所得以供可減除暫時性
　　　　　差異、虧損扣抵或研究發展及人才培訓等支出所產生之所得稅
          抵減使用時認列。
　　　　　　　與投資子公司相關之應課稅暫時性差異皆認列遞延所得稅
　　　　　負債，惟合併公司若可控制暫時性差異迴轉之時點，且該暫時性
　　　　　差異很有可能於可預見之未來不會迴轉者除外。與此類投資有
　　　　　關之可減除暫時性差異，僅於其很有可能有足夠課稅所得用以
　　　　　實現暫時性差異，且於可預見之未來預期將迴轉的範圍內，予以
　　　　　認列遞延所得稅資產。
　　　　　　　遞延所得稅資產之帳面金額於每一資產負債表日予以重新
　　　　　檢視，並針對已不再很有可能有足夠之課稅所得以供其回收所
　　　　　有或部分資產者，調減帳面金額。原未認列為遞延所得稅資產
　　　　　者，亦於每一資產負債表日予以重新檢視，並在未來很有可能產
　　　　　生課稅所得以供其回收所有或部分資產者，調增帳面金額。
　　　　　　　遞延所得稅資產及負債係以預期負債清償或資產實現當期
　　　　　之稅率衡量，該稅率係以資產負債表日已立法或已實質性立法
　　　　　之稅率及稅法為基礎。遞延所得稅負債及資產之衡量係反映合
　　　　　併公司於資產負債表日預期回收或清償其資產及負債帳面金額
　　　　　之方式所產生之租稅後果。
 　　　 3.當期及遞延所得稅
　　　　　　　當期及遞延所得稅係認列於損益，惟與認列於其他綜合損
　　　　　益或直接計入權益之項目相關之當期及遞延所得稅係分別認列
　　　　　於其他綜合損益或直接計入權益。

</ix:nonNumeric></pre></td>
					</tr>
					<tr>
						<td colspan="2">　 其他</td>
					</tr>
					<tr>
						<td style="text-align:center">項目</td>
						<td style="text-align:center">說明</td>
					</tr>
				</table>
			</div>
			<br />
			<div id="SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations">
				<table style="width:90%">
					<tr>
						<th colspan='5' style="text-align:left">重大會計判斷、假設及估計不確性之主要來源</th>
					</tr> 
					<tr>
						<td>　 重大會計判斷、假設及估計不確性之主要來源</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:SourcesOfUncertaintyFromSignificantAccountingJudgmentsAssumptionsAndEstimations" contextRef="From20230101To20231231" escape="true">
　　合併公司於採用會計政策時，對於不易自其他來源取得相關資訊
者，管理階層必須基於歷史經驗及其他攸關之因素作出相關之判斷、估
計及假設。實際結果可能與估計有所不同。
　　合併公司於發展重大會計估計值時，將全球藥品市場波動及相關
政府政策及法規可能之影響，納入對現金流量推估、成長率、折現率、
獲利能力等相關重大估計之考量，管理階層將持續檢視估計與基本假設。
估計及假設不確定性之主要來源
(一)商譽減損估計
　　　　決定商譽是否減損時，須估計分攤到商譽之現金產生單位之使
　　用價值。為計算使用價值，管理階層應估計預期自現金產生單位所產
　　生之未來現金流量，並決定計算現值所使用之適當折現率。若實際現
　　金流量少於預期，抑或現金產生單位之估計折現率發生重大改變，可
　　能會產生重大減損損失。截至資產負債表日止，合併公司評估商譽並
　　無重大之減損損失。
(二)遞延所得稅資產之可實現性
　　　　遞延所得稅資產係於未來很有可能有足夠之課稅所得供可減除
　　暫時性差異使用時方予以認列。評估遞延所得稅資產之可實現性時，
　　必須涉及管理階層之重大會計判斷及估計，包含預期未來收入成長
　　及利潤率、可使用之所得稅抵減、稅務規劃等假設。任何關於全球經
　　濟環境、產業環境的變遷及法令的改變，均可能引起遞延所得稅資產
　　之重大調整。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			</div>

			<br />
			<div id="TradeAndOtherReceivables"></div>
			<div class="title">應收款項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">明細表</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">項目及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">應收帳款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">376,369</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,482</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount2" contextRef="AsOf20231231" escape="true">其他應收款</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,607</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">12,406</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">382,976</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalTradeAndOtherReceivables" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">165,888</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:ScheduleOfTradeAndOtherReceivables" contextRef="AsOf20231231" escape="true">(一)應收帳款
　　　　合併公司之權利金收入授信期間為按季結算後30至45天收款，
　　藥品授權收入授信期間則依據授權合約訂定之收款時程，應收帳款
　　不予計息。為減輕信用風險，合併公司管理階層指派專責團隊負責相
　　關監控程序以確保逾期應收帳款之回收已採取適當行動。此外，合併
　　公司於資產負債表日會逐一複核應收帳款之可回收金額以確保無法
　　回收之應收帳款已提列適當減損損失。據此，合併公司管理階層認為
　　合併公司之信用風險已顯著減少。
　　　　合併公司按存續期間預期信用損失認列應收帳款之備抵損失。
　　存續期間預期信用損失係使用準備矩陣計算，其考量客戶過去違約
　　紀錄與現時財務狀況、產業經濟情勢及產業展望。
　　　　若有證據顯示交易對方面臨嚴重財務困難且合併公司無法合理
　　預期可回收金額，例如交易對方正進行清算，合併公司直接沖銷相關
　　應收帳款，惟仍會持續追索活動，因追索回收之金額則認列於損益。
(二)其他應收款
　　　　其他應收款除應收利息外，主係合併公司代墊藥品商業量產或
　　投入藥品研發之款項，依據授權合約將由銷售合作夥伴負擔，截至
　　112年及111年12月31日止，合併公司評估其他應收款餘額於存續
　　期間均無應認列之備抵損失。</ix:nonNumeric></pre></td>
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='6' rowspan='1' style="text-align:left">應收款項之帳齡分析</th>
					</tr>
					<tr>
						<th colspan='6' rowspan='1' style="text-align:center">帳齡區間及金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳齡區間</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">未逾期</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">373,213</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,482</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:AgeDistributionAndAmount">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:AgeDistribution" contextRef="AsOf20231231" escape="true">30天以下</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,156</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount2" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">376,369</ix:nonFraction> </pre></td>
						<td colspan='3' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalPastDueButNotImpaired" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">153,482</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='1'>說明</th>
						<td colspan='4' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:AgingAnalysisOfReceivablesThatArePastDueButNotImpaired2" contextRef="AsOf20231231" escape="true">　　以上係以逾期天數為基準進行之帳齡分析。
　　合併公司於112年及111年12月31日評估應收帳款餘額於存
續期間均無應認列之備抵損失。</ix:nonNumeric></pre></td>
					</tr>
				</table>
			<div style="text-align:center">應收款項之備抵損失變動資訊</div> 
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div id="TransactionsBetweenRelatedParties"></div>
			<div class="title">關係人交易</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<br />
			<div style="text-align:center"> 母公司及最終控制者之名稱</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='2' rowspan='1' style="text-align:left">關係人名稱及關係</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">關係人名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">關係人關係</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NameAndRelatiohshipOfRelatedParty2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfRelatedParty" contextRef="AsOf20231231" escape="true">杭州漢達醫藥科技有限公司（杭州漢達）</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyRelationship" contextRef="AsOf20231231" escape="true">自112年6月5日起為關聯企業</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
				</table>
			<br />
			<div class="title">與關係人間之重大交易事項</div>
			<div class="rptidx">單位：新臺幣仟元</div>
			<div style="text-align:center">營業收入</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">進貨</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">應收關係人款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='12' rowspan='1' style="text-align:left">應付關係人款項</th>
					</tr>
					<tr>
						<th colspan='12' rowspan='1' style="text-align:center">帳列項目及關係人類別與金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">帳列項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">關係人類別/名稱</th>
						<th colspan='2' rowspan='1' style="text-align:center">金額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年同期</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:FinancialStatementAccountAndCategoriesOfRelatedPartiesAndAmount2">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount4" contextRef="AsOf20231231" escape="true">其他應付款</ix:nonNumeric></pre></td>
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CategoriesOfRelatedParties12" contextRef="AsOf20231231" escape="true">關聯企業</ix:nonNumeric></pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount4" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,606</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount4" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						</ix:tuple>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>合計</th>
						<td colspan='1' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountsPayableToRelatedParties" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,606</ix:nonFraction> </pre></td>
						<td colspan='4' style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountsPayableToRelatedParties" contextRef="AsOf20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left" colspan='2'>說明</th>
						<td colspan='5' style="text-align:left"></td>
					</tr>
				</table>
			<div style="text-align:center">預付款項</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分不動產、廠房及設備</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分投資性不動產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分金融資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">取得其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">處分其他資產</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center">對關係人放款</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<div style="text-align:center"> 背書保證</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr>
						<td style="width:120px"> 其它</td>
						<td style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:OtherTransactionWithRelatedParties" contextRef="From20230101To20231231" escape="true">
　　本公司及子公司（係本公司之關係人）間之交易、帳戶餘額、收益
及費損於合併時全數予以銷除，故未揭露於本附註。除已於其他附註揭
露外，合併公司與其他關係人間之交易如下。

(二)研究發展費用
　　關係人類別／名稱　　　　　112年度	　　111年度
　　----------------　　　　----------     ---------
　　關聯企業                $  21,030      $      -
　　                        ==========     =========

　　　　合併公司委託關聯企業進行特定階段之試驗專案，因無同類交
　　易可循，其交易條件係由雙方協商決定。

</ix:nonNumeric></pre></td>
					</tr>
				</table>
			<div style="text-align:center">向關係人借款</div>
			<div style="text-align:center">無此情形／免揭露</div>
				<br />
				<table style="width:90%">
					<tr> 
						<th colspan='3' style="text-align:left">主要管理階層薪酬</th> 
					</tr> 
					<tr> 
						<th></th> 
						<th colspan='1'>本年度</th>
						<th colspan='1'>上年度</th>
					</tr>
					<tr>
						<th style="text-align:left">短期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">63,429</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShortTermEmployeeBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">48,902</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">退職後福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,475</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PostEmploymentBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,377</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">其他長期員工福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:OtherLongTermBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">離職福利</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TerminationBenefits" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">股份基礎給付</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,768</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ShareBasedPayment2" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">53</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">合計</th>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">70,672</ix:nonFraction> </pre></td>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalKeyManagementPersonnelCompensation" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">50,332</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<th style="text-align:left">說明</th>
						<td  colspan='3' style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:KeyManagementPersonnelCompensation2" contextRef="From20230101To20231231" escape="true">董事及其他主要管理階層之薪酬係由薪酬委員會依照個人績效及市場趨勢決定。</ix:nonNumeric></pre></td>
					</tr>
				</table>
			<br />
			<div id="LoansToOthers"></div>
			<div class="title">資金貸與他人</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='18' rowspan='1' style="text-align:left">資金貸與他人</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">貸出資金之公司</th>
						<th colspan='1' rowspan='2' style="text-align:center">貸與對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">往來項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">是否為關係人</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期最高餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末餘額</th>
						<th colspan='1' rowspan='2' style="text-align:center">實際動支金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">利率區間</th>
						<th colspan='1' rowspan='2' style="text-align:center">資金貸與性質</th>
						<th colspan='1' rowspan='2' style="text-align:center">業務往來金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">有短期融通資金必要之原因</th>
						<th colspan='1' rowspan='2' style="text-align:center">提列備抵呆帳金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">擔保品</th>
						<th colspan='1' rowspan='2' style="text-align:center">對個別對象資金貸與限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">資金貸與總限額</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">價值</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20230101To20231231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,410</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20230101To20231231" escape="true">0.01345</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20230101To20231231" escape="true">短期融通資金</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20230101To20231231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,102,524</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,102,524</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20230101To20231231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,917</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20230101To20231231" escape="true">0.015</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20230101To20231231" escape="true">短期融通資金</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20230101To20231231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,102,524</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,102,524</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20230101To20231231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">30,705</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20230101To20231231" escape="true">0.045</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20230101To20231231" escape="true">短期融通資金</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20230101To20231231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,079</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,079</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LoansToOthers">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:No." contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Lender1" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty1" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementItem" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelatedPartyTransaction" contextRef="From20230101To20231231" escape="true">是</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:MaximumBalanceForThePeriod1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">15,353</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:ActualAmountProvided" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RangeOfInterestRates" contextRef="From20230101To20231231" escape="true">0.045</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NatureOfLoans" contextRef="From20230101To20231231" escape="true">短期融通資金</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AmountOfSalesToPurchasesFromCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:ReasonForShort-termLoans" contextRef="From20230101To20231231" escape="true">營業週轉</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AllowanceForBadDebts" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:Collateral">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Item1" contextRef="From20230101To20231231" escape="true">-</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Value" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfLoanAmountForIndividualCounterparty" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,079</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:LimitOfTotalLoanAmount1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">336,079</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司資金貸與他人餘額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance1-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司資金貸與他人餘額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalEndingBalance1-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>母公司資金貸與他人實際動支金額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided1-Parent" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>子公司資金貸與他人實際動支金額合計</th> 
						<td colspan='21' style="text-align:left"><pre><ix:nonFraction name="tifrs-notes:TotalActualAmountProvided1-Subsidiaries" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
					</tr>
					<tr>
					<th style="text-align:left" colspan='4'>備註</th> 
						<td colspan='21' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-LoansToOthers" contextRef="From20230101To20231231" escape="true">註1：依資金貸與他人作業程序，本公司資金貸與有短期融通資金必要之公司或行號總額以不超過本公司最近期經會計師查核簽證或核閱財務報告淨值40%為限；個別貸與金額以不超過本公司淨值10%為限，惟個別資金
　　 貸與本公司直接及間接持有表決權股份百分之百之子公司，係以本公司淨值之40%為限。本公司直接及間接持有表決權股份百分之百之國外子公司間從事資金貸與，係以貸出資金之國外子公司淨值之40%為限。
註2：外幣金額係依112年12月31日之即期匯率換算。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="EndorsementGuaranteeProvidedToOthers"></div>
			<div style="text-align:center">為他人背書保證</div>
			<div style="text-align:center">無此情形／免揭露</div>
			<br />
			<div id="SignificantIntercompanyTransactionsBetweenConsolidatedEntities"></div>
			<div class="title">母子公司間業務關係及重要交易往來情形</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='8' rowspan='1' style="text-align:left">母子公司間業務關係及重要交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">編號</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易人名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">交易往來對象</th>
						<th colspan='1' rowspan='2' style="text-align:center">與交易人之關係</th>
						<th colspan='4' rowspan='1' style="text-align:center">交易往來情形</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">科目</th>
						<th colspan='1' rowspan='1' style="text-align:center">金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">交易條件</th>
						<th colspan='1' rowspan='1' style="text-align:center">佔合併總營收或總資產之比率</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,698</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註8</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">利息收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,375</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4及5</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">處分無形資產利益</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">40,021</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">4.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應付款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">194</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註6</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Oncology, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應付款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,997</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註7</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">0</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">利息收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">371</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註5</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">攤銷費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">130,176</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">12.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,886</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註6</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">利息收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">246</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註5</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">873</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註6</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">利息收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">457</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註5</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Oncology, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,448</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註6</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">1</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">處分無形資產利益</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">91,220</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">8.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">101,366</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">3.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">利息收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,943</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Oncology, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">其他應收款－關係人</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">25,247</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Oncology, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">利息收入</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">2,095</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">0.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">3</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">攤銷費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">11,905</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:SignificantIntercompanyTransactionsBetweenConsolidatedEntities">
						<td style="text-align:right"><pre><ix:nonNumeric name="tifrs-notes:No" contextRef="From20230101To20231231" escape="true">4</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyName" contextRef="From20230101To20231231" escape="true">Handa Oncology, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Counterparty" contextRef="From20230101To20231231" escape="true">杭州漢達醫藥科技有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:RelationshipWithTheCompany" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:IntercompanyTransactions">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:FinancialStatementAccount" contextRef="From20230101To20231231" escape="true">研究發展費用</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Amount" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">13,708</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Terms" contextRef="From20230101To20231231" escape="true">註9</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfConsolidatedOperatingRevenuesOrTotalAssets" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">1.00</ix:nonFraction>% </pre></td> 
						</ix:tuple>
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='11' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-SignificantIntercompanyTransactionsBetweenConsolidatedEntities" contextRef="From20230101To20231231" escape="true">註1：與交易人之關係有以下二種，標示種類即可：
     1.母公司對子公司。
     2.子公司對子公司。
註2：交易往來金額佔合併總營收或總資產比率之計算，若屬資產負債科目者，以期末餘額佔合併總資產之方式計算；若屬損益科目者，以期間累積金額佔合併總營收之方式計算。
註3：相關交易於編製本合併財務報告時，業已全數沖銷。
註4：係合併個體間之處分無形資產交易，係參照第三方獨立評價結果及雙方合約議定之金額收取。
註5：係母子公司間或子公司間之資金貸與，請參閱附表一。
註6：係合併個體間之代墊款項。
註7：係母子公司共同開發專案，依約應共同分攤之開發費用。
註8：係母公司發行限制員工權利新股並給與子公司員工，係參照第三方獨立評價結果之金額收取。
註9：係委託合併個體進行特定階段之研發試驗，依合約約定收付委託研究費。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence"></div>
			<div class="title">被投資公司名稱、所在地區…等相關資訊</div>
			<div class="rptidx">單位：新臺幣仟元；股數：股</div>
				<table style="width:90%">
					<tr>
						<th colspan='13' rowspan='1' style="text-align:left">被投資公司名稱、所在地區…等相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">地區別代號</th>
						<th colspan='1' rowspan='2' style="text-align:center">所在地區</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='2' rowspan='1' style="text-align:center">原始投資金額</th>
						<th colspan='3' rowspan='1' style="text-align:center">期末持股情形</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列之投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末</th>
						<th colspan='1' rowspan='1' style="text-align:center">去年年底</th>
						<th colspan='1' rowspan='1' style="text-align:center">股數</th>
						<th colspan='1' rowspan='1' style="text-align:center">比率</th>
						<th colspan='1' rowspan='1' style="text-align:center">帳面金額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">漢達生技醫藥股份有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">轉投資控股與醫藥產品之市場開發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">307,050</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">307,100</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">1,000</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">840,198</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">822,397</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">822,397</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Handa Pharmaceuticals, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">醫藥產品之研究與市場開發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,212</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">9,213</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5,567</ix:nonFraction>)</pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">74,003</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">74,003</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Handa Neuroscience, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">醫藥產品之研究與市場開發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,917</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">39,923</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">105,943</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,433</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">68,433</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestor" contextRef="From20230101To20231231" escape="true">Handa Pharma, Inc.</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvestee" contextRef="From20230101To20231231" escape="true">Handa Oncology, LLC</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:LocationCode" contextRef="From20230101To20231231" escape="true">211</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Location" contextRef="From20230101To20231231" escape="true">美國</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">醫藥產品之研究與市場開發</ix:nonNumeric></pre></td> 
						<ix:tuple name="tifrs-notes:OriginalInvestmentAmount">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:EndingBalance3" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">242,570</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BeginningBalance" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">242,609</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<ix:tuple name="tifrs-notes:InvestmentsAtTheEndOfThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NumberOfShares1" contextRef="AsOf20231231" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnership1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">100.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValue1" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31,563</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">51,962</ix:nonFraction>)</pre></td> 
						<td style="text-align:right"><pre>(<ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized1" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">51,962</ix:nonFraction>)</pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:Note" contextRef="From20230101To20231231" escape="true">註4</ix:nonNumeric></pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='18' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-NamesLocationsAndRelatedInformationOfInvesteesOverWhichTheCompanyExercisesSignificantInfluence" contextRef="From20230101To20231231" escape="true">註1：除母子公司間交易之科目餘額外，係按112年12月31日美金即期匯率換算。
註2：除母子公司間交易之交易金額外，係按112年1月1日至12月31日美金平均匯率換算。
註3：大陸被投資公司相關資訊請參閱附表四。
註4：於編製本合併財務報告時，業已全數沖銷。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="InvestmentInMainlandChina"></div>
			<div class="title">大陸地區投資</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th colspan='14' rowspan='1' style="text-align:left">轉投資大陸地區之事業相關資訊</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='2' style="text-align:center">大陸被投資公司名稱</th>
						<th colspan='1' rowspan='2' style="text-align:center">主要營業項目</th>
						<th colspan='1' rowspan='2' style="text-align:center">實收資本額</th>
						<th colspan='1' rowspan='2' style="text-align:center">投資方式</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期初自台灣匯出累積投資金額</th>
						<th colspan='2' rowspan='1' style="text-align:center">本期匯出或收回投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期期末自台灣匯出累積投資金額</th>
						<th colspan='1' rowspan='2' style="text-align:center">被投資公司本期損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">本公司直接或間接投資之持股比例</th>
						<th colspan='1' rowspan='2' style="text-align:center">本期認列投資損益</th>
						<th colspan='1' rowspan='2' style="text-align:center">期末投資帳面價值</th>
						<th colspan='1' rowspan='2' style="text-align:center">截至本期止已匯回台灣之投資收益</th>
						<th colspan='1' rowspan='2' style="text-align:center">備註</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">匯出</th>
						<th colspan='1' rowspan='1' style="text-align:center">收回</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:InformationOfInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:CompanyNameOfTheInvesteeInMainlandChina" contextRef="From20230101To20231231" escape="true">杭州漢達醫藥科技有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MainBusinessesAndProducts" contextRef="From20230101To20231231" escape="true">醫藥製劑之技術開發及服務提供</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:TotalAmountOfPaid-inCapital" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">69,228</ix:nonFraction> </pre></td> 
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:MethodOfInvestment" contextRef="From20230101To20231231" escape="true">2</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheBeginningOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<ix:tuple name="tifrs-notes:InvestmentFlowsForThePeriod">
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Outflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:Inflow" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						</ix:tuple>
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedOutflowOfInvestmentFromTaiwanAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:NetIncomeLossesOfTheInvestee" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,505</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:PercentageOfOwnershipThroughDirectAndIndirectInvestmentByTheCompany" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="-2" decimals="4" unitRef="Pure">71.00</ix:nonFraction>% </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentIncomeLossesRecognized2" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3,541</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:BookValueAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">61,864</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInwardRemittanceOfEarningsAsOfTheEndOfThePeriod" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:left"></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='17' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-InformationOfInvestmentInMainlandChina" contextRef="From20230101To20231231" escape="true">註1：係按112年12月31日美金及人民幣匯率換算。
註2：係透過第三地區投資事業Handa Pharmaceuticals, LLC再投資大陸公司，本公司於105年2月份以美金185,659元受讓取得Handa Pharmaceuticals, LLC股東所持有杭州漢達醫藥科技有限公司之所有股權。本公司董
     事會於112年4月7日決議由子公司Handa Pharmaceuticals, LLC現金增資杭州漢達醫藥科技有限公司美金1,300,000元，前述增資已於112年4月完成。
註3：係按112年1月1日至12月31日美金及人民幣平均匯率換算。
註5：係按被投資公司本年度經會計師查核之財務報告計算。
註6：如附註九所述，合併公司自112年6月5日起已喪失對杭州漢達之控制力，故將其轉列為採用權益法之投資。於112年6月5日前，本期認列之投資損益於編製合併財務報告時業已全數沖銷。
註7：係依實繳出資額比例認列。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
				<br />
				<table style="width:90%">
					<tr>
						<th colspan='4' rowspan='1' style="text-align:left">轉投資大陸地區限額</th>
					</tr>
					<tr>
						<th colspan='1' rowspan='1' style="text-align:center">公司名稱</th>
						<th colspan='1' rowspan='1' style="text-align:center">本期期末累計自台灣匯出赴大陸地區投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">經濟部投審會核准投資金額</th>
						<th colspan='1' rowspan='1' style="text-align:center">依經濟部投審會規定赴大陸地區投資限額</th>
					</tr>
					<tr>
						<ix:tuple name="tifrs-notes:LimitOnInvestmentInMainlandChina">
						<td style="text-align:left"><pre><ix:nonNumeric name="tifrs-notes:NameOfTheCompany" contextRef="From20230101To20231231" escape="true">杭州漢達醫藥科技有限公司</ix:nonNumeric></pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:AccumulatedInvestmentInMainlandChinaAtTheEndOfThePeriod" contextRef="AsOf20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:InvestmentAmountAuthorizedByTheInvestmentCommissionOfMOEA" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5,701</ix:nonFraction> </pre></td> 
						<td style="text-align:right"><pre><ix:nonFraction name="tifrs-notes:UpperLimitOnInvestmentInMainlandChinaImposedByTheInvestmentCommissionOfMOEA" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,653,785</ix:nonFraction> </pre></td> 
						</ix:tuple>
					</tr>
					<tr>
					<th style="text-align:left" colspan='1'>備註</th> 
						<td colspan='5' style="text-align:left"><pre class="note"><ix:nonNumeric name="tifrs-notes:Note-LimitOnInvestmentInMainlandChina" contextRef="From20230101To20231231" escape="true">註1：係按112年12月31日美金及人民幣匯率換算。
註2：係透過第三地區投資事業Handa Pharmaceuticals, LLC再投資大陸公司，本公司於105年2月份以美金185,659元受讓取得Handa Pharmaceuticals, LLC股東所持有杭州漢達醫藥科技有限公司之所有股權。本公司董
     事會於112年4月7日決議由子公司Handa Pharmaceuticals, LLC現金增資杭州漢達醫藥科技有限公司美金1,300,000元，前述增資已於112年4月完成。
註3：係按112年1月1日至12月31日美金及人民幣平均匯率換算。
註4：依據投審會97年8月29日「在大陸地區從事投資或技術合作審查原則」規定之限額，為本公司最近期淨值之60%。</ix:nonNumeric></pre></td> 
					</tr>
				</table>
			<br />
			<div id="NonoperatingIncomeAndExpenses"></div>
			<div class="title">營業外收入及支出</div>
			<div class="rptidx">單位：新臺幣仟元</div>
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 利息收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2023年1月1日至12月31日</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7101</td>
						<td>　　 銀行存款利息</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromBankDeposits_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,155</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncomeFromBankDeposits_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">499</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7105</td>
						<td>　　 其他利息收入</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherInterestIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">5</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherInterestIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">3</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7100</td>
						<td>　　 利息收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">18,160</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">502</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<table style="width:90%">
					<tr>
						<th style="text-align:left" colspan="4">　 其他收入</th>
					</tr>
					<tr>
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th>
						<th style="text-align:center">2023年1月1日至12月31日</th>
						<th style="text-align:center">2022年1月1日至12月31日</th>
					</tr>
					<tr>
						<td>N7190</td>
						<td>　　 其他收入－其他</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,406</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncomeOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">764</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7010</td>
						<td>　　 其他收入合計</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">72,406</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherIncome_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">764</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 其他利益及損失</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th> 
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2023年1月1日至12月31日</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
					</tr>					<tr>
						<td>N7210</td>
						<td>　　 處分不動產、廠房及設備利益(損失)</td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">5</ix:nonFraction>)</pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfPropertyPlantAndEquipment_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">2</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7225</td>
						<td>　　 處分投資利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfInvestments_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">4,612</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:GainsLossesOnDisposalsOfInvestments_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">0</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7230</td>
						<td>　　 外幣兌換利益(損失)</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">1,710</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:ForeignExchangeGainsLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">44,022</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7600</td>
						<td>　　 其他利益及損失</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">31</ix:nonFraction> </pre></td>
						<td class="amt"><pre>(<ix:nonFraction name="tifrs-notes:OtherGainsAndLossesOthers_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" sign="-" decimals="-3" unitRef="TWD">35</ix:nonFraction>)</pre></td>
					</tr>
					<tr>
						<td>N7020</td>
						<td>　　 其他利益及損失淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">6,348</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:OtherGainsAndLosses_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">43,985</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br />
				<br /> 
				<table style="width:90%"> 
					<tr> 
						<th style="text-align:left" colspan="4">　 財務成本</th> 
					</tr> 
					<tr> 
						<th style="text-align:center">代號</th>
						<th style="text-align:center">會計項目</th> 
						<th style="text-align:center">2023年1月1日至12月31日</th> 
						<th style="text-align:center">2022年1月1日至12月31日</th> 
					</tr> 
					<tr>
						<td>N7510</td>
						<td>　　 利息費用</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">222</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:InterestExpense_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">281</ix:nonFraction> </pre></td>
					</tr>
					<tr>
						<td>N7050</td>
						<td>　　 財務成本淨額</td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20230101To20231231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">222</ix:nonFraction> </pre></td>
						<td class="amt"><pre><ix:nonFraction name="tifrs-notes:FinanceCosts_n" contextRef="From20220101To20221231" format="ixt:numdotdecimal" scale="3" decimals="-3" unitRef="TWD">281</ix:nonFraction> </pre></td>
					</tr>
				</table>
			<br /> 
			</span>
		</div> 
		<br /> 
	</div> 
</body> 
</html> 

<!--This instance document is created by SIIAP V2.4.9-->

